The effect of duration of ischaemic compression on active trigger points in the infraspinatus muscle by Magoo, Anisha
COPYRIGHT AND CITATION CONSIDERATIONS FOR THIS THESIS/ DISSERTATION 
o Attribution — You must give appropriate credit, provide a link to the license, and indicate if
changes were made. You may do so in any reasonable manner, but not in any way that
suggests the licensor endorses you or your use.
o NonCommercial — You may not use the material for commercial purposes.
o ShareAlike — If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original.
How to cite this thesis 
Surname, Initial(s). (2012). Title of the thesis or dissertation (Doctoral Thesis / Master’s 
Dissertation). Johannesburg: University of Johannesburg. Available from: 
http://hdl.handle.net/102000/0002 (Accessed: 22 August 2017).    
 
 
 
THE EFFECT OF DURATION OF ISCHAEMIC COMPRESSION ON 
ACTIVE TRIGGER POINTS IN THE INFRASPINATUS MUSCLE 
 
 
A research dissertation presented to the 
Faculty of Health Sciences, University of Johannesburg, 
As partial fulfilment for the 
Master’s Degree in Technology: Chiropractic 
by 
 
 
 
Anisha Magoo 
(Student Number: 201107669) 
 
 
 
 
 
 
 
Supervisor:                                                                                Date:  
                         Dr C. Hay
ii 
DECLARATION 
I, Anisha Magoo, declare that this dissertation is my own, unaided work. It is 
being submitted as partial fulfilment for the Master’s Degree in Technology, in 
the program of Chiropractic, at the University of Johannesburg. It has not been 
submitted before for any degree or examination in any other tertiary institution. 
Anisha Magoo 
On this 8th day of the month of July 2019. 
iv 
DEDICATION 
In loving memory of  
Magrajh (Billy) Magoo & Vera Esther Magoo 
To my parents 
Pradeep Magoo & Razia Magoo 
Every success of mine belongs to you 
v 
 
 
ACKNOWLEDGEMENTS 
 
My gratitude extends to more people than I can mention, for I’ve been extremely 
blessed throughout my studies with immeasurable love and support. For this I can 
only thank the 
 Almighty, all praise be to Him. 
 
A special thank you to Mum, for walking through every step of this journey with 
me and for all you have sacrificed to make my dreams come true. To Dad, for 
always doing your best to show your love and support. 
To Sadu and Aya, two guiding lights who have paved a way forward for me. 
Thank you for taking care of me and loving me more than I deserve. 
To Aunty Florah, thank you for helping me every single day, for your company, 
opinion and late-night silent laughter. 
To my family, who would bring the sky to me if I only reached out for it. Each of 
you have contributed more to my growth than you will ever know, thank you. 
To my bonus mum, Aunty Shanitha, and our Dhiru, your love is a source of light 
and warmth that I cannot be without. 
To the most amazing friends, you have added colour to this experience. Hafiza & 
Sheetal, thank you for always cheering me on. Sharné, for not only being my 
technical support, but also being a wonderful companion. To Shiven, for your 
weekly advice, problem solving, motivation and unwavering belief in me. 
To my supervisor, Dr Hay and the Head of the Chiropractic Department, Dr 
Yelverton. To my lecturers and clinicians, as well as the staff of the University of 
Johannesburg. Thank you developing the chiropractor in me. 
To my patients at the UJ Chiropractic clinic and the participants of this study, 
thank you for being an integral part of my learning and completion of this degree. 
To everyone who has given me opportunities, imparted knowledge or advice and 
made this achievement possible for me, I thank you. 
 
vi 
 
 
ABSTRACT 
 
Ischaemic compression is a popular treatment for myofascial trigger points. It is 
easy to use, non-invasive and a relatively safe practice. Current literature regarding 
how long to perform ischaemic compression for, varies widely between a few 
seconds to a few minutes. Evidence relating to a consensus on the duration of 
ischaemic compression, does not exist. 
This study set out to determine whether 30 seconds, 60 seconds or 90 seconds 
duration of ischaemic compression could produce positive effects in terms of pain 
associated with active myofascial trigger points of the infraspinatus muscle. 
Knowledge about the efficacy of different durations of ischaemic compression may 
assist clinicians in deciding how long they should perform this modality for. This 
may allow them to develop a treatment regime that is effective, comfortable and 
efficient.  
This was a quantitative, exploratory, comparative study of thirty participants 
comprising of males and females between the ages of 18-45 years who had active 
trigger points within the infraspinatus muscle. Each participant was placed into one 
of three groups. The group they were allocated to, determined whether they would 
receive 30, 60 or 90 seconds of ischaemic compression.  
Subjective data was collected using a numerical pain rating scale which represented 
the perception of pain. Objective data was attained using the pain pressure 
algometer which measured a change in pain threshold. The rubber tip of the pain 
pressure algometer was also used to deliver the ischaemic compression at a constant 
pressure. A hypoallergenic henna paste was used to mark the location of the 
myofascial trigger point being treated so that the researcher always treated the same 
location.  
Both subjective and objective data showed that the treatment was effective in 
reducing pain. This was statistically significant. However, no statistical significance 
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was noted when determining whether ischaemic compression applied for 30, 60 or 
90 seconds was more effective than the other.  
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CHAPTER ONE 
INTRODUCTION 
1.1 Problem Statement 
Time is an important aspect of life as we know it, and even more so in the health 
care sector. Manual therapy deals with time-sensitive modalities and it is important 
to follow evidence-based protocols in terms of the duration of these modalities 
(Sran, 2004). Applying a treatment for less time than recommended may be 
ineffective, whereas as prolonging its application may prove to be harmful or may 
not provide any additional benefits. Many of these modalities produce some 
discomfort. Therefore, their duration should be as short and concise as possible to 
achieve the maximal beneficial effect.  
Ischaemic compression is used widely in the treatment of myofascial trigger points 
(Cagnie, Dewitte, Coppieters, van Oosterwijck, Cools & Danneels, 2013). The 
aspect of duration of ischaemic compression is important to ensure the best possible 
result regarding pain relief whilst limiting patient discomfort as much as possible. 
Current literature regarding how long to perform ischaemic compression for, varies 
widely between a few seconds to a few minutes. Evidence relating to a consensus 
on the duration of ischaemic compression, does not exist. Thus, this study 
comparing three different frequently used time frames of ischaemic compression, 
proposes to answer this question.  
 
1.2 Aim 
The aim of this study was to determine whether 30 seconds, 60 seconds or 90 
seconds duration of ischaemic compression is the most effective in the treatment of 
pain of active myofascial trigger points of the infraspinatus muscle.  
 
1.3 Method 
A quantitative, exploratory, comparative study of thirty participants comprising of 
males and females between the ages of 18-45 years who had active trigger points 
within the infraspinatus muscle, were recruited by means of an advertisement that 
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was placed around the University of Johannesburg, Doornfontein and Auckland 
Park campuses, and by word-of-mouth. Participants who met the inclusion and 
exclusion criteria were divided through random allocation into three groups of ten 
participants each. 
Prospective participants received the information form and the consent form 
pertaining to the study. A case history, full physical and a cervical regional 
examination were performed to screen out any potential exclusion criteria. 
Participants were randomly allocated into groups. Active infraspinatus trigger 
points were identified and marked with a henna pen. Group A received 30 seconds 
of ischaemic compression to the infraspinatus trigger point; group B received 60 
seconds of ischaemic compression to the infraspinatus trigger point; and group C 
received 90 seconds of ischaemic compression to the infraspinatus trigger point. 
Subjective data was evaluated by means of a numerical pain rating scale (NPRS).  
Objective data was collected by means of a pressure algometer to determine pain 
threshold. Subjective and objective data was collected prior to the treatment on the 
first, fourth and seventh consultations. 
The application of ischaemic compression was carried out using the pressure 
algometer. It has a blunt rubber tip and a consistent amount of pressure of 3.5 
kg/cm2 could be measured and sustained for a duration determined by the group 
allocation.  
Data was collected by the researcher and analysed by Mrs. Juliana Van Staden at 
STATKON of the University of Johannesburg using the following statistical tests: 
One-way ANOVA, Post-Hoc, Kruskal-Wallis, Mann Whitney, Repeated Measures 
ANOVA, Friedman and Wilcoxon Signed-rank.  
 
1.4 Outcome 
The possible outcome of the study was that either 30 seconds, 60 seconds or 90 
seconds of ischaemic compression was superior in reducing the pain of an active 
trigger point within the infraspinatus muscle. Another possible outcome was that 
none of the proposed durations have a significant difference in efficacy. This would 
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still be a valuable result as it would suggest that even the shortest proposed duration 
was as effective as the others. A secondary possible outcome would be to clarify 
for manual therapists, chiropractors and physiotherapists the most effective 
duration when treating active trigger points of the infraspinatus muscle. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Introduction 
The purpose of this chapter was to provide the reader with an adequate 
understanding of the topics directly related to the study. The literature provided in 
this chapter was derived from academic sources which have become the foundation 
upon which this research study was built. Therefore, to make sense of its design, 
purpose and outcomes it is necessary to explore previous research. Themes to be 
highlighted include the related anatomy, ischaemic compression and duration.  
 
2.2 Skeletal Muscle  
2.2.1 Anatomy 
Skeletal muscle is part of the musculoskeletal system and is responsible for 
voluntary movement and stabilization of bones and joints. They also generate heat. 
Although skeletal muscles are largely under voluntary control, they are also able to 
respond to stimuli to produce a reflex output. Skeletal muscle is composed of 
striated muscle fibres that are contractile, as well as non-contractile connective 
tissue (Moore, Dalley & Agur, 2017). Muscles have two different ways in which 
their fibres may be arranged i.e. longitudinal and pennate. Longitudinal muscle 
fibres are arranged parallel along the length of a muscle. Pennate fibres lie obliquely 
in relation to the length of the muscle (Muscolino, 2010). Muscles with pennate 
arrangements could more specifically be described as unipennate, bipennate or 
multipennate. The most basic unit of skeletal muscle that exists is the muscle fibre. 
A muscle fibre is made up of many myofilaments which come together to form a 
myofibril. Many muscle fibres held together by connective tissue produce a whole 
muscle (Tyldesley & Grieve, 2002).  
The connective tissue surrounding the whole muscle is called the epimysium and 
continues to form the tendon of the muscle. The perimysium is the sheath of 
connective tissue surrounding each bundle of muscle fibres. Furthermore, each 
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muscle fibre is coated by another layer of connective tissue termed the endomysium 
(Seidman, 2017).  
 
Figure 2.1: Gross anatomy of muscle (Whittier, 2019) 
 
The muscle fibre is a multinucleated cell enclosed by a cell membrane called the 
sarcolemma. The nuclei are arranged close to the sarcolemma. Two major proteins 
make up the myofibril. They are actin and myosin (Tyldesley & Grieve, 2002). 
Actin have a smaller cross-sectional diameter in comparison to myosin and are 
therefore known as thin fibres. Myosin fibres are called thick fibres. Sarcomeres 
are joined to each other from end to end at junctions called Z-lines (Dixon, Drum 
& Weatherwax, 2016). Actin filaments are connected to the Z-lines and project into 
the middle of the sarcomere. Myosin filaments are found in between the actin. Actin 
and myosin overlap, forming the dark bands that could be seen when viewing 
muscle fibres under a microscope (Tyldesley & Grieve, 2002). Myosin filaments 
have projections called the myosin heads. Myosin heads are able to connect to actin 
filaments to form cross-bridges (Muscolino, 2010).  
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Figure 2.2: The sarcomere, actin & myosin (Whittier, 2019) 
 
2.2.2 Physiology 
As previously stated in this chapter, one of the main functions of skeletal muscle is 
movement. This is achieved through muscle contractions which pull on skeletal 
structures to create gross movement. Muscles could produce various types of 
contractions. Skeletal muscles typically perform concentric contractions, eccentric 
contractions and isometric contractions.  
A concentric contraction is achieved when the muscle involved is shortened during 
the contraction. The muscle is moved toward the centre of the muscle belly. In doing 
so it also moves at least one joint that it crosses. By shortening, it approximates its 
attachments. Eccentric contractions are described as those in which the muscle is 
lengthened during the contraction. This type of contraction occurs when the force 
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opposing the contraction is greater than the force produced by the muscle. 
Movement occurs in the joint crossed by the muscle. However, this movement is 
away from the centre of the muscle. An isometric contraction is a contraction of a 
muscle that results in no change in length of the muscle. This could be observed 
when the force generated by the muscle equals the force resisting movement, 
therefore no movement occurs (Muscolino, 2010).  
A muscle contraction occurs on a cellular level after receiving a stimulus from the 
nervous system. Motor neurons are found within skeletal muscles. They carry 
stimuli from the central nervous system which dictate the action to be carried out 
by the muscle. A synapse is the junction between the end of the motor neuron and 
the muscle. The impulse crosses the synapse from the motor end plate to the muscle 
with the use of neurotransmitters. These neurotransmitters are released by the motor 
neuron into a gap called the synaptic cleft. Once the neurotransmitters are deposited 
into the synaptic cleft, they go on to attach to receptors found on the membrane of 
the muscle (Tyldesley & Grieve, 2002). The muscle membrane is known as the 
sarcolemma and it surrounds the cytoplasm of the muscle cell which is called the 
sarcoplasm. A transmembrane potential exists across the sarcolemma. This means 
that there are equal positive and negative charges throughout the surface of the 
membrane. When neurotransmitters are coupled with the receptors found on the 
membrane, they cause a shift in the balance of positive and negative charges. The 
transmembrane potential is disturbed, and an action potential is created (Martini & 
Nath, 2009). 
Transverse tubules (T-tubules) are channels that extend from the sarcolemma. They 
erupt perpendicular to the sarcolemma and penetrate the depth of the muscle fibre. 
The action potential travels via the T-tubules and reaches the sarcoplasmic 
reticulum where calcium is stored. This calcium is released into the sarcoplasm 
where it binds to troponin. When troponin binds to calcium it moves, thus exposing 
the actin binding site to myosin (Martini & Nath, 2009). Myosin is now able to bind 
to actin, forming cross-bridges between the filaments. With the use of Adenosine 
Triphosphate (ATP) as a source of energy, the myosin heads bend toward the 
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middle of the sarcomere pulling the actin filaments in this direction therefore 
shortening the sarcomere (Muscolino, 2010). 
 
Figure 2.3: The sliding filaments during muscle contraction (Whittier, 2019) 
 
This is a typical concentric contraction (Muscolino, 2010). For the contraction to 
stop, the neural stimulus that began the excitation- contraction cycle must cease. 
Enzymes are released that proceed to break down neurotransmitters present in the 
synaptic cleft. The transmembrane potential returns and calcium is actively 
transported back into the sarcoplasmic reticulum for storage. As the level of calcium 
available in the sarcoplasm decreases, calcium detaches from troponin. The actin 
and myosin binding breaks and the binding site is once again covered by 
tropomyosin (Frontera & Ochala, 2014). Once the contraction is over, the 
sarcomeres do not return to their resting length (Martini & Nath, 2009). 
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2.3 Infraspinatus muscle 
2.3.1 Anatomy 
The infraspinatus muscle is a member of the rotator cuff group (Muscolino, 2010). 
The rotator cuff is a musculotendinous unit that comprises of four muscles. They 
are: the supraspinatus muscle, the infraspinatus muscle, the subscapularis muscle 
and the teres minor muscle. These muscles originate on the scapula bone and come 
together, joining their tendons on the humerus. Here they form a cuff that serves to 
stabilize and move the glenohumeral joint (Bain & Giacomo, 2015).  
The infraspinatus muscle could be located on the dorsal aspect of the human body. 
It could be described as lateral to the spine and medial to the glenohumeral joint. 
The scapula is a flat bone which articulates with the humerus at the glenohumeral 
joint. The glenohumeral joint is especially mobile and therefore relies on dynamic 
stabilization from the muscles which cross it. The scapula and the clavicle articulate 
at the acromioclavicular joint, and the scapula also shares a pseudo-joint with the 
dorsal aspect of the thoracic wall. Features of the scapula include the scapular spine, 
the coracoid process and the acromion. Four fossae are present on the scapula 
namely, the glenoid fossa, the subscapular fossa, the supraspinous fossa and the 
infraspinous fossa (Moore et al., 2017). 
The infraspinous fossa is the most relevant to this study as it is the origin of the 
infraspinous muscle. The infraspinous fossa is found below the spine of the scapula. 
The medial three quarters of it is where the infraspinatus muscle attaches. The 
inferior part of the scapular spine also serves as a proximal attachment for this 
muscle (Moore, Dalley & Agur, 2017). Some of the fibres of the infraspinatus 
muscle originate from the nearby fascia of the inferior part of the trapezius, 
rhomboid and serratus anterior muscles (Donnelly, 2019). The fibres of the 
infraspinatus muscle run laterally to insert onto the middle facet of the posterior 
aspect of the greater tubercle of the humerus. This is where its tendon contributes 
to the formation of the rotator cuff (Bain & Giacomo, 2015). Connections have been 
noted between the fascia of the infraspinatus and the deltoid muscle. The 
infraspinatus tendon merges superiorly and posteriorly with the glenohumeral joint 
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capsule and fuses with the supraspinatus tendon lateral to the scapular spine 
(Donnelly, 2019). 
 
 
Figure 2.4: Osteology of the scapular bone (Jones, 2018) 
 
The infraspinatus muscle has a superior, middle and inferior part. The fibres of the 
superior portion are orientated horizontally, whereas the middle and inferior 
portions appear in a superolateral direction. These two portions end in the central 
thickened tendon. The middle partition has a well-defined band which is fibrous 
and inserts deep to the superior and inferior partitions. It attaches to the middle and 
superior facet as the supraspinatus muscle does. The deeper fibres converge with 
the supraspinatus muscle superiorly and traverse the rotator cuff interval. It then 
attaches to the subscapularis tendon. Together, they form the thick, fibrous structure 
referred to as the rotator cable. The rotator cable functions as a link between the 
anterior and posterior rotator cuff muscles. This link allows force transmission from 
the posterosuperior rotator cuff to the anterior rotator cuff. This is how the rotator 
cuff is able to display precise coordination throughout shoulder movements 
(Donnelly, 2019).  
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Amongst the four rotator cuff muscles, in terms of force production capacity, the 
infraspinatus muscle is the second greatest force producer after the subscapularis 
muscle (Bain & Giacomo, 2015). This may be attributed to its irregular shape 
(Donnelly, 2019). It receives neural stimuli via the suprascapular nerve. This nerve 
is rooted at the fifth and sixth cervical nerve roots (Moore et al., 2017). The 
infraspinatus muscle receives blood from the suprascapular artery and the 
circumflex scapular artery (Muscolino, 2010).  
 
2.3.2 Function 
The infraspinatus muscle works together with the muscles that form the rotator cuff 
to produce movement at the shoulder. These are intricate and synchronized. 
Together they produce an inferior and medial force to counter the superior and 
lateral force of the deltoid muscle. This allows the humeral head to remain in close 
contact with the glenoid fossa during shoulder movement. It also prevents superior 
translation of the humeral head which could cause impingement syndromes 
(Donnelly, 2019). Other than its function to stabilize the glenohumeral joint 
together with the rest of the rotator cuff, the infraspinatus muscle laterally rotates 
the arm (Moore et al., 2017).  
Due the horizontal position of the fibres of the superior belly, external rotation from 
0° to 10° may be solely attributed to the infraspinatus muscle (Donnelly, 2019). 
According to Muscolino (2010), there are texts that suggest that the infraspinatus 
muscle could function as an adductor as well as an abductor of the arm. Research 
also states that it passively restrains the humeral head against posterior dislocation 
and dynamically retrains it against anterior dislocation (Donnelly, 2019). 
Peak performance of the infraspinatus muscle has been reported under the following 
conditions: a) prone position, b) arm abducted in the horizontal plane, c) between 
90° and 100° of arm abduction, and d) full external rotation. Peak intensity is 
reached at 165° of abduction. Activity in this muscle could be noted before 
movement of the humerus during flexion of the glenohumeral head, scaption and 
abduction in the coronal plane. When contracting eccentrically the infraspinatus is 
one of the primary decelerators in the throwing arm as well as in the follow-through 
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arm with regards to the golf swing. Maximal activity in the infraspinatus is observed 
during a fast overhead throw and moderate activity is seen in pushing and pulling 
activities (Donnelly, 2019).  
 
2.3.3 Pathology 
Like many skeletal muscles, the infraspinatus could develop myofascial trigger 
points. Trigger points are taut bands within a muscle which cause pain and alter 
function. They are described in detail later in this chapter. When present and active 
in this muscle, they may cause shoulder pain that is experienced deep into the 
glenohumeral joint. They may produce referred pain experienced primarily in the 
anterior deltoid region, along the medial border of the scapula, in the suboccipital 
area and may also affect the posterior cervical region. Many subjects report referred 
pain into the anterolateral aspect of the arm, the lateral forearm as well as the hand 
and fingers. When asked to demonstrate where the pain is experienced, patients 
with active infraspinatus trigger points placed a hand over the anterior aspect of the 
shoulder (Donnelly, 2019; Kwon, Kim, Chang, Park & Lee, 2017). 
Pain produced by trigger points in the infraspinatus muscle may be present at rest. 
However, pain could also be experienced during activation of the infraspinatus 
muscle. Patients often experience pain and discomfort at night when lying on the 
affected side. Other symptoms include fatigue of the shoulder, decreased grip 
strength, restriction of shoulder mobility and hyperhidrosis along the pain referral 
area. The symptoms of infraspinatus trigger points may mimic nerve root radicular 
pain and carpal tunnel syndrome. They may be accompanied by trigger points in 
the other rotator cuff muscles and as well as the deltoid, rhomboid and trapezius 
muscles amongst others (Donnelly, 2019). 
 
2.4 Neural Tissue 
2.4.1 Receptors 
Receptors are defined as structures that are sensitive to changes in the environment 
or sensory units that are responsive to specific stimuli. They may simply be neurons 
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or more specialized cells (Martini & Nath, 2009). They are responsible for detecting 
sensory information that is relayed to the nervous system (Guyton & Hall 
, 2013). 
There are five types of sensory receptors, each responsible for the detection of 
specific stimuli. They are: mechanoreceptors, thermoreceptors, nociceptors, 
electromagnetic receptors and chemoreceptors. Mechanoreceptors are active when 
mechanical deformation of tissue occurs. Thermoreceptors pick up changes in 
temperature. Some thermoreceptors are sensitive to a decrease in temperature and 
others are sensitive to an increase in temperature. Nociceptors are pain receptors 
responsible for the detection of physical and chemical damage to tissue. 
Electromagnetic receptors are present on the retina of the eye and detect light. 
Chemoreceptors detect many factors related to the chemistry of the body such as 
taste, smell, blood oxygen levels etc. (Guyton & Hall, 2013). 
 
2.4.2 Axons 
Axons are nerve fibres which carry impulses to and from the central nervous 
system. The speed at which an axon propagates a nerve impulse depends on the 
diameter of the axon as well as the amount of myelination it has. The thicker an 
axon is, the faster it can carry an impulse. Greater myelin allows for greater speed 
(Martini & Nath, 2009; Perge, Janos, Niven, Mugnaini, Balasubramanian & 
Sterling, 2013).  
Axons are classified into three types depending on their diameter and myelination. 
They are type A, B and C fibres. Type A fibres are large and well myelinated and 
therefore carry impulses at great speeds. Type A fibres relay sensory information 
regarding position, balance, light touch and most relevant to the current study; 
pressure. These axons also carry information from the central nervous system to 
skeletal muscles for motor functions. Type B fibres are smaller, but myelinated and 
allow for propagation at moderate speed. Type C fibres have the smallest diameter 
and are not myelinated, thus carrying impulses at the lowest speed. Type B and C 
fibres carry impulses for temperature and pain sensations. They also relay 
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instructions from the central nervous system to smooth muscle, cardiac muscle and 
glands etc. (Martini & Nath, 2009). 
2.5 The Pain Gate theory 
The pain gate theory was proposed by Melzack and Wall in 1965 as an alternative 
pain mechanism to the specificity theory and the pattern theory. In summary, the 
pain gate theory states that a gated control of pain exists within dorsal horn of the 
spinal cord as the substantia gelatinosa. Nerve impulses are sent to the spinal cord 
when receptors in the skin are stimulated. These impulses are carried to the cells of 
the substantia gelatinosa, the dorsal-column fibres projecting toward the brain and 
the T cells in the dorsal horn. According to Melzack and Wall, the interaction of 
these three systems determines the perception of pain within the brain.  
The substantia gelatinosa modulates afferent impulses that reach the dorsal horn. 
These impulses arrive at the dorsal horn via axons of different types. The types most 
relevant to the pain gate theory are the type A fibres and type C fibres (Melzack & 
Wall, 1965). As previously discussed in this chapter, type A fibres carry impulses 
of touch and pressure, and type C fibres carry impulses of pain (Martini & Nath, 
2009). The arrival of an impulse via type C fibres opens the pain gate. However, 
when an impulse is brought to the dorsal horn via a type A fibre, the substantia 
gelatinosa modulates the pain stimulus by closing the pain gate. The T cells then 
receive less information regarding the pain stimulus and more regarding the touch 
and pressure stimuli. Therefore, the perception of touch and pressure in the brain 
overrides the perception of pain (Melzack & Wall, 1965). 
 
2.6 Myofascial Trigger points 
2.6.1 History 
The study of myofascial trigger points (MTrP’s) could be dated as far back as the 
16th century when what is now known as myofascial pain syndrome was first 
described. Later it was Dr Janet Travell who made tremendous progress in trigger 
point research in the 1900s. It was in the early 1960s that Dr David Simons began 
working together on the topic of myofascial trigger points (Dommerholt, Bron & 
15 
 
Franssen, 2006). This resulted in many publications, including the Trigger Point 
Manuals which have been an essential reference for the manual therapy profession 
(Simons, Travell & Simons, 1999). 
2.6.2 Definition 
Myofascial trigger points are defined by Simons, Travell and Simons as “a 
hyperirritable spot in skeletal muscle that is associated with a hypersensitive 
palpable nodule in a taut band. The spot is painful on compression and could give 
rise to characteristic referred pain, (or other symptoms) referred tenderness, motor 
dysfunction and autonomic phenomena”. The definition in terms of the etiology is 
“a cluster of electrically active loci each of which is associated with a contraction 
knot and a dysfunctional motor end plate in skeletal muscle”. They could be 
described as active or latent trigger points. An active trigger point is one that 
produces symptoms whereas a latent MTrP does not cause pain until it is stimulated. 
Latent MTrP’s may result in restricted movement and muscle inhibition (Simons, 
Travell & Simons, 1999).  
 
2.6.3 Etiology 
The etiology of MTrP’s is multi-faceted. Many factors must be considered in terms 
of diet, physical activity or inactivity, previous injury, biomechanical dysfunction 
as well as conditions which may cause secondary dysfunction of skeletal muscles 
amongst others. The overuse of skeletal muscle is a major cause of MTrP’s. 
Repetitive movements and sustained contraction in both acute episodes and chronic 
periods could perpetuate a physiological process which results in a taut band in the 
muscle. The muscle is unable to respond appropriately to the stress being applied 
and thus is subject to overloading. Muscle function is impaired, and an energy crisis 
is initiated. Excessive muscle activity as a cause of MTrP’s could be classified as 
either postural or structural (Donnelly, 2019). 
Postural strain is a common cause of MTrP’s. It could be further broken down into 
static or dynamic (repetitive) categories. Metabolic processes may also contribute 
to the formation of MTrP’s. Poor diet resulting in deficiencies of vitamins B and D, 
Magnesium, and Iron. Conditions which affect the absorption, metabolism or 
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transportation of these vitamins and minerals would also result in MTrP’s. 
Hypermetabolic conditions, hormonal changes and the adverse effects of drugs are 
also involved. Conditions such as Ehlers-Danlos syndrome which present with joint 
hypermobility also affect muscle function. The central nervous system could 
undergo neuroplastic changes which contributes to myofascial pain syndromes 
(Donnelly, 2019). 
 
2.6.4 Pathophysiology 
As previously mentioned, a taut band is characteristic of a MTrP. The taut band is 
formed when the intracellular calcium is released in high and abnormal volumes in 
response to trauma, overload or stress. The excessive calcium initiates sarcomere 
shortening that is uncontrolled. An increased metabolism occurs within the muscle 
due to the influx of calcium. Local circulation is reduced due to the tension created 
by the sustained contraction. This results in insufficient oxygen and nutrients 
supplied to the muscle. An energy crisis is created, and this process becomes a 
pathological cycle. The area becomes deficient in high-energy phosphates, and rich 
in low-energy phosphates and creatine (Hong & Simons, 1998).  
 
2.6.5 Diagnosis 
The diagnosis of MTrP’s is reliant on a complete clinical picture. The patient history 
could provide insight into the various factors which may contribute to MTrP’s. 
Their daily habits, work environment, posture, physical activities, stress and diet 
may allow the examiner to begin to understand what the cause of their symptoms 
might be. The location of the pain would indicate which muscles might be involved. 
MTrP’s have specific pain referral patterns. Palpation of a taut band which 
reproduces the symptoms experienced could justify diagnosis of the MTrP. A local 
twitch response upon palpation is regarded as one of the diagnostic criteria. Muscle 
testing could be used to identify muscle weakness. Assessing the range of motion 
of the involved joint would be helpful in detecting restriction of movement due to 
MTrP’s (Donnelly, 2019). 
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2.6.6 Treatment 
Various methods have proven successful for the treatment of MTrP’s. Myofascial 
dry needling is minimally invasive but yields great results (Segeel, Hay & Lawson, 
2008). Electrical stimulation, ultrasound, LASER and shockwave therapy are also 
effective in treating MTrP’s when available and depending on the site of the MTrP. 
Manual therapy however remains one of the preferred and most effective ways to 
decrease pain sensitivity, hypertonicity and stiffness associated with MTrP’s. It 
increases circulation, relaxation and flexibility. It could be applied in the form of 
massage, ischaemic compression and many more related techniques. However, for 
this study ischaemic compression was the chosen method and is discussed further. 
 
2.7 Ischaemic Compression 
2.7.1 Introduction 
Ischaemic Compression (IC) is an aspect of trigger point therapy alongside dry 
needling, muscle energy technique and deep tissue massage to mention a few. It is 
also called Trigger Point Compression Release (TPCR). Since 1957, chiropractors 
have employed ischaemic compression for the treatment of myofascial trigger 
points. It has been put forward as one of the most effective methods for treating 
myofascial pain syndromes (Gatterman & McDowell, 2012).  
 
2.7.2 Definition 
Simons et al. defined ischaemic compression as “trigger point pressure release” and 
explained that it is applied by gradually increasing pressure that is not painful to a 
trigger point and ceased when a barrier of tissue resistance is reached. He explains 
that the pressure must be maintained until the tissue barrier gives way. Pressure is 
increased to reach a new barrier and remove the trigger point tension and pain 
(Simons et al., 1999). According to Iqbal and Khan, the technique of ischaemic 
compression is applying sustained pressure to the trigger point. This is done with 
enough force and for a duration that slows down the blood flow and forces the 
tautness out of the muscle (Iqbal & Khan, 2010). Therefore, one could deduce that 
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IC comprises of three simple components: a) firm pressure, b) onto a specific 
myofascial trigger point, and c) for some time.  
2.7.3 Application 
Pressure 
Regarding the aspect of pressure, it is generally applied manually using the fingers 
and/or thumb. Instrument assisted ischaemic compression is also recommended and 
produces good results. A study completed in 2010 reported that ischaemic 
compression using the Backnobber Ⅱ was effective in reducing the symptoms 
myofascial trigger points (Gulick, Palombaro & Lattanzi, 2011). For this study, the 
rubber tip of a pain pressure algometer was used to ensure an equal and quantifiable 
amount of pressure amongst all subjects.  
The amount of pressure used for ischaemic compression has generally been applied 
at a pressure that is dictated by pain tolerance (Hains, 2002). However, an 
unpublished study has shown no statistical difference between the efficacies of 
ischaemic compression applied at pain threshold as opposed to pain tolerance. 
Ischaemic compression at pain tolerance subjects the patient to the greatest amount 
of pressure that they could bear. Ischaemic compression at pain threshold uses less 
force as the clinician only applies enough pressure to initiate pain. Since ischaemic 
compression has been reported as equally effective in both cases, it would be in the 
patient’s best interest to apply ischaemic compression at pain threshold (Ismail, Hay 
& Yelverton, 2014). 
Researchers have used pressure algometry to collect data regarding mean values for 
pressure pain threshold of various muscles. For this project, four different studies 
have been analysed to determine a suitable pressure at which ischaemic 
compression would be delivered to the infraspinatus muscle.  
A 2011 Korean study to determine the reliability and usefulness of the pressure pain 
threshold measurement in patients with myofascial pain used a digital algometer to 
measure the pressure pain threshold of eight muscles in two hundred and twenty-
two subjects. For the infraspinatus muscle, the mean value was 4.5 kg/cm2 (Park, 
Kim, Park, Kim & Jang, 2011). 
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A South African study comparing the effects of different treatments on trigger 
points of the infraspinatus muscle used a hand held algometer to measure pressure 
pain threshold in thirty people. This study reported a mean value of 2.95 kg/cm2 
during the first visit and a mean value of 4.05 kg/cm2 during the seventh visit 
(Cloete & Bester, 2012). 
Another South African study comparing the effect of treatment of infraspinatus 
trigger points applied at two different sites also used a handheld pressure algometer 
to attain objective data. It found an initial mean value of 4.07 kg/cm2 and a final 
mean value of 5.20 kg/cm2 amongst thirty patients (Hutchinson, Yelverton & 
Whelan, 2014). 
A similar study exploring the effect of treatment on fascial tension of thirty 
participants used pressure algometry on infraspinatus and found an initial mean of 
1.9 kg/cm2 and a final mean of 3.2 kg/cm2 (Parker & Landman, 2015). 
In the interest of reliability of this project, ischaemic compression was delivered at 
a predetermined pressure to all its’ participants. Research has shown variable 
pressure pain threshold measurements for infraspinatus. Taking this into account, a 
constant pressure of 3.5 kg/cm2 was used for this study. 
Location 
Ischaemic compression could only yield positive outcomes when it is applied to the 
correct location. As previously discussed, a MTrP is a hyperirritable spot within 
skeletal muscle. When treating muscles with ischaemic compression it is important 
to be specific in locating the site of the trigger point. This is achieved by palpating 
the muscle for the taut band associated with trigger points. Reproduction of the pain 
referral pattern or symptoms experienced by the patient would serve as an 
indication for the site at which treatment should be applied (Hains, 2002).  
Depending on the muscle affected, the trigger point could be pinched between the 
practitioners’ fingers using a pincer grip. Muscles that cannot be held in this manner 
such as the infraspinatus muscle, are pinned down against underlying structures by 
applying pressure directly onto the trigger point (Bosch & Moodley, 2014). 
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Figure 2.5: Position when locating an infraspinatus trigger point (photo by 
researcher, 2018) 
 
Duration 
Practitioners vary in the amount of time that they sustain pressure on the trigger 
point during ischaemic compression. One research study used ischaemic 
compression on the levator scapulae muscles and sustained the compression for 90 
seconds (Bosch & Moodley, 2014). Researchers applying ischaemic compression 
to the neck and shoulder muscles did so for 60 seconds (Cagnie et al., 2013). An 
article describing the effect of ischaemic compression for the treatment of 
cervicogenic cephalic syndrome stated that the treatment was delivered for 30 
seconds at a time (Lin, Lai, Chang, Lin & Chou, 2012). The variance of duration 
between practitioners is a cause for research to justify the appropriate use of time 
when treating MTrP’s with IC. Ravichandran, Ponni & Aseer (2016) recommend 
further research to validate the duration of ischaemic compression. This study 
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compared the effects of ischaemic compression at each of the aforementioned 
durations.  
 
Mechanism of action 
The aim of trigger point therapy is to release tension and increase blood flow within 
the myofascial trigger point. The application of ischaemic compression aids the 
removal of intramuscular waste products by increasing local circulation. This 
results in muscle relaxation (Manzoor & Afzal, 2016). A recent study by Sonmezer 
aimed to determine the change in tissue temperature after the application of 
ischaemic compression and myofascial release. This would indicate the effect that 
these modalities have on local circulation. He found an increase in the temperature 
of the targeted tissue after the application of ischaemic compression followed by 
myofascial release. This indicates a positive increase in vascularisation following 
ischaemic compression (Sonmezer, 2018).  
 
Turchaninov describes three effects of ischaemic compression in Powers of 
Compression. These effects aid the understanding of the mechanism of ischaemic 
compression. They are: a) the stimulation of local metabolism, b) the release of 
vasoactive substances, and c) reflex vasodilation (Turchaninov, 2011). 
a) The stimulation of local metabolism 
The application of compression to a MTrP at pain threshold causes mild trauma to 
the capillaries located in the area. As a result, bleeding occurs at a microscopic 
level. Blood cells leak into the adjacent tissues and initiate an immune response. 
Macrophages and T-cells infiltrate the area to remove the blood cells. The outcome 
of this process is an increase in local metabolism (Turchaninov, 2011). 
 
b) The release of vasoactive substances 
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Histamine and other substances which act on blood vessels are released upon the 
application of direct pressure. The effect of histamine is vasodilation and fibroblast 
release. Vasodilation increases local blood flow and fibroblasts repair the damaged 
tissue (Turchaninov, 2011).  
 
c) Reflex vasodilation 
A MTrP is characterised by a taut band within a muscle (Simons et al., 1999). This 
tension reduces the blood profusion within the MTrP and starves the muscle of 
oxygen and nutrients. The compression applied during ischaemic compression 
further increases tension to a point of ischaemia. No blood can reach the MTrP, but 
the heart continues to pump blood to the surrounding area. This oxygen and nutrient 
rich blood collects around the MTrP at a high pressure due to the blockage created 
by the compression being applied. Once the direct pressure is released, the large 
amount of blood that had been accumulating around the MTrP rushes into the MTrP 
due to the change in pressure. The nervous system produces a reflex vasodilation 
and oxygenation returns to the area (Turchaninov, 2011).  
 
Benefits  
Ischaemic compression is a preferred method of trigger point therapy due to its ease 
of use and minimal risk. It is non-invasive and a relatively safe practice (Gatterman 
& McDowell, 2012). Even though it could be applied with an instrument, it is 
generally a manual practice (Gulick, Palombaro & Lattanzi, 2011).  This lowers the 
cost factor as compared to other modalities such as dry needling which require a 
variety of consumables. Ischaemic compression is applied for a short period which 
also contributes to its popularity. It has been reported to be most effective in 
conjunction with other therapeutic modalities such as ultrasound (Aguilera, Botella, 
Martin, Masanet, Morell & Soler, 2009) and muscle energy techniques (Nambi, 
Sharma, Inbasekaran, Vaghesiya & Bhatt, 2013). 
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2.8 Henna   
2.8.1 Introduction 
Henna is a paste made from the leaves of the Lawsonia Inermis plant. It belongs to 
the Lythraceae family and is known for its medicinal uses and its potential as a 
natural dye (Hekmatpou, Ahmadian, Eghbali & Farsaei, 2018). The use of henna is 
documented as far back as the year 1912. It is mentioned in the Papyrus, where four 
hundred plants are mentioned as the basis of eight hundred and seventy-six 
remedies (Gallo, Multari, Palazzino, Pagliuca, Zadeh, Biapa & Nicoletti, 2014).  
 
2.8.2 Usage 
In Europe, the use of henna was aesthetic and art related. Hair tinting with henna 
became fashionable. In Asia, henna is rooted in culture and religion. Muslim 
women were encouraged to dye their nails and fingers using the henna paste to 
display femininity. The ceremonial use of henna during weddings, births, 
circumcision etc. signifies joy and celebration, and is widely in use today. During 
the special occasions, henna paste is used for body art especially on the hands and 
feet. Henna has also become popular in western parts of the world as its use for 
temporary tattoos is widely accepted (Gallo et al., 2014).   
For this study, an organic henna paste was used. This paste developed a brownish- 
orange tint. Henna which produces tints of different colours especially black, have 
artificial colourants added to the paste. This may have adverse effects and result in 
skin irritations. However, when organic, brown-orange henna is used it is relatively 
hypoallergenic (Vepachedu, 2014). When using henna, it is advisable to test the 
product on a small area of skin. This was done for each participant in this study. 
None of the participants reported any adverse reactions. 
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Figure 2.6: Brown-orange colour stain produced by using organic henna 
(photo by researcher, 2018) 
 
The literature presented in this chapter was used to develop the reasoning and 
method that was discussed in the chapter that follows. The current study was carried 
out according to the method described in chapter three. 
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CHAPTER THREE 
METHODOLOGY 
 
3.1 Introduction 
This chapter serves as a complete guide to the method used to execute this research 
study. The study design, management of participants, treatment protocol and data 
collection are to be described in detail. This clinical trial was designed to highlight 
the aspect of duration when using ischaemic compression for the treatment of active 
myofascial trigger points. It was performed at the University of Johannesburg 
Chiropractic Clinic under the supervision of certified and experienced 
chiropractors.  
 
3.2 Study Design 
This study was quantitative, experimental and comparative. A quantitative design 
was best suited as the outcomes were measurable by means of both subjective and 
objective data collection tools. The numerical pain rating scale (NPRS) represented 
subjective feedback and the pain pressure algometer (PPA) allowed the researcher 
to collect objective data throughout the clinical trial. It was comparative as three 
groups of participants were treated with ischaemic compression of various 
durations. The results across the groups were then analysed and compared to 
highlight the similarities and differences that the duration of ischaemic compression 
may have on its efficacy when treating active myofascial trigger points.  
The pain pressure algometer was also used to apply the ischaemic compression, as 
opposed to conventional manual application. This served to eliminate changes in 
pressure which may have affected the outcomes of the study. It allowed a constant 
pressure throughout the treatment as well as between participants. It could therefore 
be deduced that differences in the efficacy of ischaemic compression found in this 
study could be linked to differences in the time/duration instead of differences in 
the pressure used. 
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Figure 3.1: Rubber tip of the pain pressure algometer (photo by researcher, 
2018) 
 
3.2.1 Participant recruitment 
Recruitment was aimed at the population in and around the University of 
Johannesburg (UJ) Doornfontein campus. This allowed ease of compliance with the 
requirements of this project i.e. the need for participants to visit the clinic twice 
weekly over a three-week period. To create interest in the clinical trial, posters 
(appendix A) were placed on notice boards at the UJ Chiropractic Clinic. The same 
was done around the Doornfontein, Auckland Park, Bunting and Soweto campuses. 
Distribution at all the UJ campuses was beneficial as students and staff members of 
UJ have access to free inter-campus transportation. Word of mouth proved to be a 
valuable tool to inform potential participants of the study. Pre-existing patrons of 
the UJ Chiropractic Clinic were told about the research project. The same 
information was conveyed to other students and staff members at UJ.  
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3.2.2 Sample selection and size 
The study recruited thirty participants for the clinical trial. Males and females 
between the ages of 18 and 45 years old were considered as potential participants. 
They were assessed in terms of the inclusion and exclusion criteria mentioned 
below. Those who were suitable for the study were asked to report to the clinic for 
an initial consultation which is discussed in detail later in this chapter. Once full 
compliance was confirmed by participants, they were randomly placed into three 
groups with ten participants in each group. The group allocation determined the 
duration of the intervention used. 
Group A: 30 seconds of ischaemic compression (N=10) 
Group B: 60 seconds of ischaemic compression (N=10) 
Group C: 90 seconds of ischaemic compression (N=10) 
 
3.2.3 Inclusion criteria 
To be included into this study, participants had to meet the following inclusion 
criteria: 
• Male or female 
• Aged between 18 and 45 years. Persons under the age of 18 years were excluded 
from the study. According to the Department of Health, the participation of minors 
in a study is approved only when it is well motivated. Approval is not likely if the 
exclusion of minors does not affect the outcome of the study. Consenting adults are 
preferred when the topic undergoing investigation does not concern minors 
specifically (Department of Health, 2006).  The effect of the duration of ischaemic 
compression on active trigger points of the infraspinatus muscle can be investigated 
without the inclusion of persons under the age of 18.  Participants over the age of 
18 were able to give consent for their own participation.  
People over the age of 45 years were excluded to minimise the complication of age-
related degenerative changes to the shoulder complex. The incidence of 
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degenerative shoulder pathology is found to gradually increase between the ages of 
50 and 65 on average (Vincent & Leboeuf-yde, 2017). The older population was 
also excluded on the premise that pain sensitivity changes with age. As people age, 
their pain pressure threshold may decrease (Cole, Farrell, Gibson & Egan, 2010). 
The current study required ischaemic compression to be applied at the average pain 
pressure threshold of the infraspinatus muscle. In older people, the pressure applied 
may not have been suitable.  
• Participants were required to have active myofascial trigger points of the 
infraspinatus muscle. This was determined during history taking and palpation of 
the infraspinatus muscle.  
 
3.2.4 Exclusion criteria 
Participants who displayed any of the following characteristics were excluded from 
this study.   
• Altered sensitivity to pressure or pain. Participants who displayed 
paraesthesia, anaesthesia or dysaesthesia during the neurological 
examination were disqualified. People with decreased or no sensitivity to 
pressure or pain may have been harmed during the application of ischaemic 
compression. They may have also been harmed during the PPA data 
collection. The altered perception of pressure or pain would also result in 
unreliable feedback between treatments. 
• Pre-existing pathology of the shoulder that was involved in the study. This 
may have affected the perception of shoulder pain. The researcher would 
have difficulty isolating pain produced by the myofascial trigger point from 
pain because of unrelated shoulder pathology.  
• Low tolerance of the set amount of pressure (3.5 kg/cm2) onto the 
myofascial trigger point. If participants cannot tolerate 3.5 kg/cm2 of 
pressure onto the myofascial trigger point to be treated, the intervention 
procedure cannot be performed. 
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• Contra-indications to ischaemic compression as listed by Simons et al.   
(1999): 
1. Patients with vascular compromise, impingement, disease or 
aneurysm; 
2. Acute rheumatoid arthritis or any other systemic disease; 
3. Chronic diseases such as lupus or cystic fibrosis; 
4. Cancer and malignancy; 
5. Fractures, open wounds, trauma, sprain, strain and bruises; 
6. Any condition associated with fever, nausea, weight loss and 
neurological problems; 
7. Severe acute or chronic pain or acute inflammation.  
Contraindications no longer reflect in the latest (2018) edition of the source. 
 
3.2.5 Group allocation  
Participants were grouped into one of three groups, i.e. group A, group B or group 
C. The group allocation was randomly determined by the participant who picked a 
folded label out of a transparent container. The label chosen revealed which group 
they were placed into; namely: 
• Group A: treated with 30 seconds of ischaemic compression 
• Group B: treated with 60 seconds of ischaemic compression 
• Group C: treated with 90 seconds of ischaemic compression. 
 
3.3 Treatment Approach  
3.3.1 First and follow-up visits 
The first consultation began with a brief explanation of the study and what it entails. 
An information sheet (appendix B) with the details of the research project was 
handed to the participant for them to read through and keep. Any questions and/or 
concerns were discussed at this point. Once the participant was satisfied they were 
asked to sign a consent form (appendix C). Next, a thorough history was explored 
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(appendix E), and the participant was asked to complete a numerical pain rating 
scale (appendix D) regarding their shoulder pain. This was followed by a physical 
examination (appendix F), a cervical spine examination (appendix G) and a 
shoulder examination (appendix H). Once it was clear that the participant was 
eligible for the study, a summary of the consultation was compiled using a form 
that has headings for the subjective findings, objective findings, assessment and 
procedure. This form is therefore called a SOAP note (appendix I). The researcher 
proceeded with the intervention process. The second, third, fifth and sixth visits was 
used for the intervention procedure and recording of findings on a SOAP note 
(appendix I). During the fourth visit the pain rating scale (appendix D) was 
completed again, objective readings were acquired, and the intervention was carried 
out. The seventh visit was only used to record subjective and objective data. 
Treatment 
The intervention proceeded as follows: 
• The participant was prepared for the procedure. This entailed explaining the 
procedure in terms of what the participant can expect to experience as well as the 
importance of maintaining communication throughout the session. 
• The participant was adequately exposed whilst maintaining patient modesty as far 
as possible. 
• The area to be treated was inspected and sanitized using an alcohol swab. A small 
amount of henna was applied to the skin to test for an allergic reaction. If a reaction 
occurred, the henna was removed immediately. If no reaction occurred, the 
researcher proceeded to the next step. 
• The infraspinatus muscle was palpated to locate the myofascial trigger point that 
would be treated. 
• This specific point was marked with a henna stain (semi-permanent, hypoallergic 
stain). 
31 
 
 
Figure 3.2: Patient position during the intervention (photo by researcher, 
2018) 
 
• Next, ischaemic compression was applied to the trigger point using the algometer 
at a standard pressure of 3.5 kg/cm2. This was sustained at either 30, 60 or 90 
seconds depending on which group the participant had been allocated to. 
•The participant was monitored to make sure that the pressure applied is tolerated 
well. Communication was maintained throughout the intervention process to ensure 
adequate feedback. 
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Figure 3.3: Flow diagram depicting clinical method 
The effect of duration of ischaemic 
compression on active trigger points in 
the infraspinatus muscle 
 
• Receive information sheet (appendix B) 
• Sign consent form (appendix C) 
• Clinical Assessment (appendices E-I) 
• Numerical Pain Rating Scale (appendix D)  
Group A – 30 seconds  
 
Group C – 90 seconds  
 
Measurement  
• NPRS 
• PPA 
Treatment  
• 90 seconds of IC 
 
Visit 1: 
Measurement 
Treatment 
Exclusion Criteria Inclusion Criteria  
Participant excluded 
Group B – 60 seconds  
Measurement  
• NPRS 
• PPA 
Treatment  
• 30 seconds of IC 
 
Measurement  
• NPRS 
• PPA 
Treatment  
• 60 seconds of IC 
 
Visit 2 & 3: 
 Treatment 
Visit 4: 
Measurement 
Treatment 
Visit 5 & 6: 
      Treatment 
Visit 7: 
Measurement 
Study Completed 
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3.3.2 Subjective data  
Subjective data was collected using the Numerical Pain Rating Scale (NPRS). The 
scale begins with the number zero, which correlates with no pain at all. It ends with 
the number ten which is associated with the worst pain imaginable by the patient 
(Bijur, Gallagher & Latimer, 2003). The NPRS has been found to be a beneficial 
tool to convey pain intensity as well as to monitor changes in pain experienced. The 
NPRS has also been documented as a preferred pain rating scale amongst patients 
as it is simple to complete (Hoggart & Williamson, 2005). 
 
3.3.3 Objective data  
Pressure algometry using a handheld algometer quantified the effects of the 
ischaemic compression by measuring the amount of force that is required to reach 
pain threshold. The rubber tip of the algometer is used to contact the skin over the 
active myofascial trigger point. The researcher applies downward pressure through 
the rubber tip of the algometer. The patient is instructed to tell the researcher when 
pain can be felt. Pressure algometry provides insight into the resultant changes 
associated with treatment of trigger points (McCarthy, Oldham & Potter, 2006). 
Studies have shown that the values produced by the algometer may be reproduced 
well enough to hold statistical value and therefore is adequate for clinical use 
(Ylinen, 2007). The algometer presents high intra-rater reliability for the 
measurement of pressure pain threshold (Park et al, 2011). 
 
Figure 3.4: Pain pressure algometer (photo by researcher, 2018) 
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3.4 Data analysis 
Data was collected by the researcher and analysed by Mrs Juliana Van Staden of 
STATKON at the University of Johannesburg. The raw data was analysed in terms 
of frequencies and descriptives to create a general understanding. The Crosstabs 
test was then performed to view the gender distribution across the groups. Next, the 
Shapiro-Wilk test was used to test for normality. Since normality was not noted, 
non-parametric tests were adopted for the rest of the statistical analysis. The 
Kruskal-Wallis test was used to test for variance between groups (intergroup). The 
Friedman test tested variance of each subject at different points in time (intragroup).  
Post-hoc testing was then applied to the data to compare the results at the different 
points in time that were analysed by the Friedman test. The Wilcoxon Signed Rank 
test was employed for this. All these tests were applied to both the objective ad 
subjective data collected. 
 
3.5 Ethical considerations 
All participants that wished to partake in this study were requested to read the 
information form (Appendix B) and sign the consent form (Appendix C) specific 
to this study. The information and consent form outlined the names of the 
researcher, purpose of the study and benefits of partaking in the study, participant 
assessment and treatment procedure. Any risks, benefits and discomforts pertaining 
to the treatments involved were also explained and that the participant’s safety 
would be ensured (prevention of harm). The information and consent form also 
explained that the participant’s privacy would be protected as only the doctor, 
patient and clinician would be in the treatment room and that anonymity would be 
ensured as the patient information would be converted into data and therefore could 
be traced back to the individual. The form also stated that standard doctor/patient 
confidentiality would always be adhered to when compiling the research 
dissertation. The participants were informed that their participation is on a 
voluntary basis and that they are free to withdraw from the study at any stage. When 
the participant had any further questions, they were 
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explained by the researcher; whose contact details were made available. The 
participants were then required to sign the information and consent form, signifying 
that they understand all that was required of them for this study. Results of the study 
were made available on request. 
Regarding this study, the risks or dangers are limited. However, patients may have 
experienced a fair amount of post-treatment stiffness and/or soreness. The benefits 
of treatment may have been an increase in pain threshold and an overall decrease in 
the negative effects of trigger points. 
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CHAPTER FOUR 
RESULTS 
 
4.1 Introduction 
This chapter serves to display the data collected during the clinical trial performed 
for this study. The data represented below was produced over seven visits at the UJ 
Chiropractic Clinic. Three groups of participants represented three different 
durations of ischaemic compression. The results from all three groups were 
quantified using the NPRS and PPT. Thirty participants were recruited. This was a 
small sample size and therefore is not representative of the entire population. The 
p-values produced were considered significant at less than or equal to 0.05 (p ≤ 
0.05). 
The data analysis included: 
• Demographic data regarding age and gender distribution  
• Subjective data represented by the NPRS 
• Objective data using the PPA 
 
4.2 Analysis of demographic data 
Table 4.2 Demographic data 
Characteristics Group A 
(n = 10) 
Group B 
(n = 10) 
Group C 
(n = 10) 
Age (SD)  25.20 (1.476) 24.90 (2.025) 25.10 (1.370) 
Age min-max 24-28 23-30 23-28 
Age median 
(years) 
24.50 24.50 25.00 
Gender distribution: 
Male 5 (50%) 4 (40%) 5 (50%) 
Female 5 (50%) 6 (60%) 5 (50%) 
Total 10 10 10 
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The overall age of participants ranged between 23 and 30 years old. The sample 
consisted of a total of 30 people. There were 15 males and 15 females participating.  
In group A the youngest participant was 24 years old and the oldest participant was 
28 years old. The mean age was 25.20 (SD ± 1.476) years. The median age was 
24.50 years. There was a total of 10 participants in group A, 5 of which were male 
and 5 were female. There was a gender distribution of 50% of each gender. 
In group B the youngest participant was 23 years old and the oldest participant was 
30 years old. The mean age was 24.90 (SD ± 2.025) years. The median age was 
24.50 years. There was a total of 10 participants in group B, 4 of which were male 
and 6 were female. There was a gender distribution of 40% males and 60% females. 
In group C the youngest participant was 23 years old and the oldest participant was 
28 years old. The mean age was 25.10 (SD ± 1.370) years. The median age was 
25.00 years. There was a total of 10 participants in group C, 5 of which were male 
and 5 were female. There was a gender distribution of 50% of each gender. 
 
4.3 Tests for normality 
Tests for normality are used to determine whether parametric or non-parametric 
tests should be used to further analyse the data collected. If the outcome of the test 
shows normality within the sample, parametric tests are used. If no normality was 
shown, non-parametric tests were employed for data analysis. The Shapiro-Wilk 
test was used to test for normality throughout the study due to its small sample size 
of 30 participants. No normality was reported for data produced throughout the 
clinical trial. Therefore, non-parametric tests were employed for both intragroup 
and intergroup analysis. For intragroup analysis, the Friedman test was used. The 
Wilcoxon Signed Rank test was employed for Post-hoc testing. For intergroup 
analysis, the study used the Kruskal-Wallis test. 
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4.4 Analysis of data 
Table 4.2 Group means and standard deviation of visit 1 and visit 7 for NPRS 
and PPA: differences between groups and differences within groups 
 Visit 1 Visit 7 Percentage 
change 
between 1-7 
Difference 
within 
groups 
Statistical 
significance 
NPRS 
Group A 
n=10 
6.40 ± 1.4 1.00 ± 1.0 54 p = 0.005 Significant 
Group B 
n=10 
6.00 ± 1.3 1.30 ± 1.2 47 p = 0.004 Significant 
Group C 
n=10 
5.70 ± 2.1 0.50 ± 0.7 52 p = 0.005 Significant 
Difference 
between groups 
p = 0.725 p = 0.238    
Statistical 
Significance 
Not 
significant 
Not 
significant 
   
PPA 
Group A 
n=10 
2.90 ± 0.9 5.04 ± 1.2 91.5 p = 0.015 Significant 
Group B 
n=10 
2.60 ± 0.9 5.25 ± 0.8 121.6 p = 0.005 Significant 
Group C 
n=10 
2.69 ± 0.9 5.96 ± 2.4 127.8 p = 0.005 Significant 
Difference 
between groups 
p = 0.867 p = 0.615    
Statistical 
Significance 
Not 
significant 
Not 
significant 
   
A: 30 seconds of IC; B: 60 seconds of IC; C: 90 seconds of IC; NPRS: Numerical 
Pain Rating Scale (0 → 10); PPA: Pain Pressure Algometer (kg/cm2) 
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4.4.1 NPRS 
The subjective data was represented by the values produced by the NPRS. Table 
4.2 shows the NPRS mean at visit 1 and 7, percentage change between visit 1 and 
7, and the p-values and statistical significance between and within groups.   
a) Intragroup analysis 
Regarding group A, the mean NPRS produced at visit 1 was 6.40 (SD ± 1.4). At 
visit 7, the mean was 1.00 (SD ± 1.0). Therefore, the change over the intervention 
period was 5.40 which represents a 54% change. Therefore, on statistical analysis 
a p-value of 0.005 was calculated which was statistically significant (p ≤ 0.05).  
For group B, the mean NPRS produced at visit 1 was 6.00 (SD ± 1.3). At visit 7, 
the mean was 1.30 (SD ± 1.2). Therefore, the change over the intervention period 
was 4.70 which represents a 47% change. Therefore, on statistical analysis a p-
value of 0.004 was calculated which was statistically significant (p ≤ 0.05). 
 For group C, the mean NPRS produced at visit 1 was 5.70 (SD ± 2.1). At visit 7, 
the mean was 0.50 (SD ± 0.7). Therefore, the change over the intervention period 
was 5.20 which represents a 52% change. Therefore, on statistical analysis a p-
value of 0.005 was calculated which was statistically significant (p ≤ 0.05). 
b) Intergroup analysis 
The Krukal-Wallis test analysed the NPRS between all three groups for visit 1 and 
7. The difference between groups at visit 1 was 0.725 and was not statistically 
significant (p > 0.05). The difference between groups at visit 7 was 0.238. This was 
not statistically significant (p > 0.05). 
 
4.4.2 PPT 
The objective data is represented by values produced by the PPA. Table 4.2 shows 
the PPA mean at visit 1 and 7, percentage change between visit 1 and 7, and the P-
values and statistical significance between and within groups.   
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a) Intragroup analysis 
Regarding group A, the mean PPA produced at visit 1 was 2.90 kg/cm2 (SD ± 0.9). 
At visit 7, the mean was 5.04 kg/cm2 (SD ± 1.2). Therefore, the change over the 
intervention period was 2.14 kg/cm2 which represents a 91.5% change. Therefore, 
on statistical analysis a p-value of 0.015 was calculated which was statistically 
significant (p ≤ 0.05).  
For group B, the mean PPA produced at visit 1 was 2.60 kg/cm2 (SD ± 0.9). At visit 
7, the mean was 5.25 kg/cm2 (SD ± 0.8). Therefore, the change over the intervention 
period was 2.65 kg/cm2 which represents a 121.6% change. Therefore, on statistical 
analysis a p-value of 0.005 was calculated which was statistically significant (p ≤ 
0.05).  
For group C, the mean PPA produced at visit 1 was 2.69 kg/cm2 (SD ± 0.9). At visit 
7, the mean was 5.96 kg/cm2 (SD ± 2.4). Therefore, the change over the intervention 
period was 3.27 kg/cm2 which represents a 127.8% change. Therefore, on statistical 
analysis a p-value of 0.005 was calculated which was statistically significant (p ≤ 
0.05).   
b) Intergroup analysis 
The Krukal-Wallis test analysed the PPA between all three groups for visit 1 and 7. 
The difference between groups at visit 1 was 0.867 and was not statistically 
significant (p > 0.05). The difference between groups at visit 7 was 0.615. This was 
not statistically significant (p > 0.05). 
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CHAPTER FIVE 
DISCUSSION 
 
5.1 Introduction 
In this chapter, the results presented in chapter four were interpreted and discussed. 
The relationship between the data produced by the clinical trial described in chapter 
three and the literature reviewed in chapter two have been explored. The outcome 
of this study would then be linked to its practical application and possible impact 
on practitioners and patients regarding ischaemic compression. 
The effect of 30 seconds, 60 seconds and 90 seconds of ischaemic compression on 
myofascial trigger points of the infraspinatus muscle in terms of pain was tested. 
The results of this experiment has been be discussed in terms of demographics as 
well as subjective and objective data within and between groups. 
 
5.2 Demographic Data  
The study included 30 participants who were randomly and evenly placed into three 
groups (10 per group). Both the 30 second and 90 second groups were made up of 
5 males and 5 females each. The 60 second group had 4 males and 6 females in it. 
In total, 14 males and 16 females participated in this study.  
The prevalence of MTrP’s is slightly higher in females compared to males 
(Delgado, Romero & Escoda, 2009). Therefore, the gender distribution of this study 
was in line with the epidemiology of MTrP’s. The difference in gender distribution 
between the groups was statistically insignificant (p > 0.05), therefore the groups 
were comparable in terms of gender.  
The mean age across groups was very similar at 25.2 years in the group that received 
30 seconds of ischaemic compression, 24.9 years in the 60 second group, and 25.1 
years in the 90 second group. The difference in mean age between the groups was 
not statistically significant (p > 0.05). Therefore, the intergroup analysis of 
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subjective and objective data was not affected by the age distribution between 
groups and the groups were deemed comparable. 
The age of participants ranged between 23 and 30 years old. The mean age within 
the population of the study was 25 years. According to Delgado, Romero and 
Escoda (2009), trigger points are commonly found in people between the age of 
27.5 and 50 years. Therefore, the age range of the study was close to the expected 
prevalence of MTrP’s. 
As discussed in chapter two, a major cause of MTrP’s is overuse resulting in 
microtrauma. This may be due to postural or structural overuse (Donnelly, 2019). 
Participants of the study were of an age group where the likelihood of activities 
leading to muscle overuse is generally high. Thus, both postural strain and overuse 
may be the reason of the age distribution displayed in chapter four.  
 
5.3 NPRS 
5.3a) Intragroup analysis 
The NPRS values improved between visit 1 and visit 7 in all three groups. The 
improvement was statistically significant (p ≤ 0.05). Therefore, all three durations 
tested were effective over time in reducing the pain experienced by participants.  
 
5.3b) Intergroup analysis 
Regarding the baseline values, the difference in the NPRS between the 30 second 
group, 60 second group and 90 second group was not statistically significant. This 
indicates that the groups were comparable. The difference of NPRS values between 
the groups at the final visit was not significant. This demonstrates that neither 30 
seconds, 60 seconds nor 90 seconds was more effective than the other in decreasing 
NPRS scores.  
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5.3c) Discussion of NPRS analysis 
Previous research has shown positive effects on the pain perception of patients 
based on the NPRS. Many studies have also used the Visual Analogue Scale (VAS) 
for subjective data collection. The VAS is very similar to the NPRS, as the VAS 
uses a graphic scale that ranges from “no symptom” to “worst imaginable degree 
of symptom” (Phan, Blome, Fritz, Gerss, Reich, Ebata & Augustin, 2015).  
MTrP’s cause both local and referred pain (Donnelly, 2019), a taut band is created 
within the muscle when an excess of calcium floods sarcomere and results in 
uncontrolled muscle contraction. Local microtrauma occurs along with an energy 
crisis and a high level of noxious metabolites which results in pain (Hong & 
Simons, 1998). Pain is produced when free nerve endings with large receptive fields 
are stimulated. Painful sensations are carried by two types of axons i.e. Type A-
delta and Type C fibres (Martini & Nath, 2009). According to the pain gate theory 
proposed by Melzack and Wall (1965), the cells of the substantia gelatinosa 
modulate the pain stimulus in the dorsal horn before its perception in the brain. 
Stimulation of large, well myelinated afferent neurons results in the closure of the 
“gate” and a decreased perception of pain. Nociceptors are small and either less 
myelinated or unmyelinated compared to mechanoreceptors which have a greater 
diameter and myelination (Guyton & Hall, 2013). Thus, the stimulation of 
mechanoreceptors during ischaemic compression could account for the decreased 
perception of pain reflected by the decrease of NPRS scores.  
 
Ismail et al. (2014), attributed the improvement of NPRS scores after the 
application of IC at pain threshold and pain tolerance to pain modulation. 
Compression of myofascial trigger points has been shown to increase 
parasympathetic activity and decrease sympathetic activity in the pre-frontal cortex. 
This was visualised using near infrared spectroscopy (Morikawa, Takamoto, 
Nishimaru, Taguchi, Urakawa, Sakai, Ono & Nishijo, 2017). 
Previous research has been conducted that used 30 seconds, 60 seconds and 90 
seconds of IC, but none have directly compared each in one study.  
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Esparza, Aladro-gonzalvo and Rybarczyk (2019) have used 30 seconds of IC to 
treat latent trigger points of the upper limb. They have reported a 95% improvement 
in pain perception using the VAS after the intervention. 
A study carried out to determine the efficacy of IC for cervicogenic headaches 
treated its participants with 30 - 60 seconds of IC at a time. The intervention was 
successful in decreasing the intensity of the headaches measured by VAS (Jafari, 
Bahrpeyma & Togha, 2017).  
Another study by Kim, Oh, Choi and Kim (2013), tested the effects of IC after 
trigger point injection for the treatment of MTrP’s of the upper trapezius muscle. 
They tested ischaemic compression for 30 seconds in one group of participants, and 
for 60 seconds in another group. This study found that both durations of IC were 
effective in lowering VAS scores significantly but found no significant difference 
between 30 seconds and 60 seconds of treatment.  
A comparative study between IC and dry needling in myofascial pain syndrome 
used IC for 90 seconds. Ischaemic compression used in this study showed a 
significant reduction in VAS scores (Molinero De Paula, Melo De Paula, Justi, 
Soares & Sanchez, 2018).  
The current study has shown a statistically significant (p ≤ 0.05) change in NPRS 
values with the use of IC for 30 seconds, 60 seconds and 90 seconds which is 
consistent with the findings of the abovementioned research. However, when 
comparing the final NPRS scores between each of the groups, no statistically 
significant difference was found. Therefore, based on these findings it may be 
proposed that the effects leading to an improvement in NPRS scores are achieved 
within 30 seconds of IC. 
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5.4 PPA 
5.4a) Intragroup analysis 
The analysis of each group between visit 1 and 7 showed an increase in PPA values 
for all groups. This change was statistically significant and means that IC was 
effective over time. 
 
5.4b) Intergroup analysis 
At visit 1, the difference in the PPA values between the 30 second group, 60 second 
group and 90 second group was not statistically significant. Therefore, all three 
groups were comparable. 
At visit 7, the difference in PPA values between the groups was not significant. This 
means that neither of the three groups show statistically significant superiority over 
the other in terms of the PPA.  
 
5.4c) Discussion of PPA analysis 
The increase in PPA measures after the application of IC may be as a result of the 
elimination of the MTrP (Cagnie et al., 2013). Ischaemic compression achieves this 
by initiating reactive hyperaemia as well as an immune response. Reflex 
vasodilation occurs when the pressure applied is removed. Histamine floods the 
area and vasodilation occurs. This improves local blood perfusion and tension 
within the muscle is reduced. The oxygen and nutrient rich blood aids in the 
removal of waste and the repair of the muscle and its capillaries.  Macrophages and 
T-cells remove waste products and local metabolism is stimulated. The muscle 
relaxes and returns to a normal state (Turchaninov, 2011). Once the MTrP is no 
longer hypersensitive, the pain threshold decreases.  
Ischaemic compression has been successful in increasing pain pressure threshold 
over MTrP’s when applied for 30 seconds (Esparza, Aladro-gonzalvo &  
Rybarczyk, 2019). When 30-60 seconds of IC was used to treat MTrP’s related to 
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cervicogenic headaches, the pain pressure threshold increased significantly 
compared to the control group (Jafari, Bahrpeyma & Togha, 2017).  
Irwin, Yelverton and Whelan (2012) reported that IC for 60 seconds on the 
rhomboid muscle produced a 35.4% improvement in PPA readings between the first 
and last treatment. IC for 60-90 seconds improved PPA readings significantly in a 
study comparing the effect of IC and therapeutic ultrasound for the treatment of 
trapezius MTrP’s  (Martin et al., 2009).  
Using 90 seconds of IC, Ferro, Rezende, Apolinario, Guirro, Rangon & Ferreira 
(2018) achieved a statistical improvement in the pain pressure threshold of breast 
cancer survivors with MTrP’s when treated with both IC and kinesiotherapy.  
The current study has produced similar evidence regarding PPA values for all three 
durations of IC. Each duration improved pain threshold as other research using the 
same durations have. However, the intergroup analysis of PPA suggests that the 
effects achieved by IC that improves pain threshold begin to take place with the 
first 30 seconds.   
 
5.5 Overall Discussion 
Limited literature indicates that the efficacy of the duration of IC has not been 
evaluated thoroughly. Research evaluating the effects of trigger point injection and 
IC for MTrP’s, investigated the difference between 30 seconds and 60 seconds of 
IC. No statistical difference was found between groups of participants who received 
either 30 seconds or 60 seconds of IC, but the results of the clinical trial suggested 
that IC was effective in decreasing pain associated with MTrP’s (Kim, Oh, Choi & 
Kim, 2013). Taking this into consideration along with the results produced by the 
current study, it could be deduced that IC is equally effective when applied for 30 
seconds, 60 seconds, or 90 seconds. This suggests that either of the above-
mentioned durations of IC could be used to treat MTrP’s in terms of pain.  
In clinical practice, knowledge regarding the efficacy of treatment modalities for 
specific durations is necessary to create effective treatment strategies. Many 
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treatment modalities elicit discomfort or pain, but their benefits outweigh the 
uncomfortable or painful experience. Ischaemic compression is one of these 
modalities. The longer IC is applied for, the more uncomfortable it is for the patient 
as well as the practitioner applying it. This may affect the overall experience from 
the consultation and prevent the patient from completing the treatment schedule set 
out. To relieve MTrP’s, practitioners may cause other muscles to develop 
hypertonic states because of exposure to the stress associated with IC for more time 
than necessary. If IC is effective when applied for as little as 30 seconds as the 
current study suggests, then 60 and 90 seconds of IC should not be used. Thirty 
seconds is sufficient to produce a statistically significant improvement in MTrP’s. 
Based on the results of the current study, it does not appear that IC for longer than 
30 seconds has any beneficial effect on the pain tolerance or subjective pain 
associated with myofascial trigger points. 
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CHAPTER SIX 
CONCLUSION 
 
6.1 Conclusion 
A statistically significant improvement was noted for all three durations over time. 
However, no statistically significant difference was shown between each of the 
durations. Therefore, ischaemic compression at 30 seconds, 60 seconds and 90 
seconds are all similarly effective for the treatment of myofascial trigger points. 
This study may have a positive effect on the chiropractic profession as well as other 
manual therapists who use IC. It provides knowledge that would assist clinicians in 
making an informed decision regarding the duration that IC should be applied for 
to achieve a positive result. Clinicians may use the knowledge that IC is as effective 
when applied at 30 seconds, 60 seconds, or 90 seconds to improve the comfort of 
the patient and themselves whilst achieving the desired effect in the shortest amount 
of time.  
 
6.2 Recommendations 
The following recommendations may be implemented to improve research 
methodology regarding the duration of IC: 
• A larger sample size may be used to better represent the population 
• The short and long-term efficacy of IC at different durations could be tested. 
This study only investigated the short-term effect of 30 seconds, 60 seconds, 
and 90 seconds of IC. 
• The efficacy durations of IC could be compared in acute versus chronic 
cases. 
• The efficacy of less than 30 seconds of IC could be tested. A study tested 
the efficacy of IC followed by stretching used only 5 seconds of IC. This 
study was successful in treating MTrP’s with this method (Menakam & 
Kalaichandran, 2015). Hains, Hains, Descarreaux & Bussières (2007) found 
good results with 5-15 seconds of IC for the treatment of MTrP’s in relation 
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with urinary incontinence. In 2010, the same researchers applied 15 seconds 
to the trapezius muscle to treat chronic shoulder pain effectively (Hains, 
Descarreaux & Hains, 2010). Ischaemic compression ranging from 20 
seconds to 60 seconds combined with muscle energy technique was 
effective in treating MTrP’s of the trapezius muscle (Nambi et al., 2013).  
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 Appendix A - Advertisement 
                                                 
RESEARCH 
THE EFFECT OF DURATION OF ISCHAEMIC COMPRESSION ON ACTIVE TRIGGER 
POINTS IN THE INFRASPINATUS MUSCLE 
Do you suffer from shoulder pain? 
 
  
If you are between the ages of 18 and 45 years, you may be eligible 
to participate in a research study treating shoulder pain of muscular 
origin. 
Ethics clearance number: REC-01-77-2018 
To be assessed or for more information, please contact  
Anisha Magoo on 072 869 2241 
 
Reach out 
for HELP! 
 
 Appendix B - Information Letter 
 
 
 
 DEPARTMENT OF CHIROPRACTIC 
RESEARCH STUDY INFORMATION LETTER 
 
Date: _________________________ 
 
Good Day 
 
My name is Anisha Magoo. I WOULD LIKE TO INVITE YOU TO PARTICIPATE in a 
research study on the effect of duration of ischaemic compression on active trigger points in 
the infraspinatus muscle. 
 
Before you decide on whether to participate, I would like to explain to you why the research 
is being done and what it will involve for you. I will go through the information letter with 
you and answer any questions you have. This should take about 10 to 20 minutes. The 
study is part of a research project being completed as a requirement for a Master’s Degree 
in Chiropractic through the University of Johannesburg. 
 
THE PURPOSE OF THIS STUDY is to determine how long a specific treatment called 
“ischaemic compression” should be applied onto a shoulder muscle before it relieves pain. 
Ischaemic compression is a treatment tool used by manual therapists which involves putting 
some pressure onto a muscle to relieve pain and tightness in the muscle. 
 
Below, I have compiled a set of questions and answers that I believe will assist you in 
understanding the relevant details of participation in this research study. Please read through 
these. If you have any further questions I will be happy to answer them for you. 
 
DO I HAVE TO TAKE PART? No, you don’t have to. It is up to you to decide to participate 
in the study. I will describe the study and go through this information sheet. If you agree to 
take part, I will then ask you to sign a consent form.  
 
WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE?  If you 
agree to participate in this study, you will be expected to visit the UJ Chiropractic Clinic twice 
 a week for three consecutive weeks and once more thereafter. You will be expected to 
participate in a consultation session which will involve a case history conversation and a 
physical examination. You will be required to numerically rate your pain and allow the 
researcher to use a device to measure your pain threshold. During the examination and 
intervention process, you will be required to expose your shoulder region. However, this will 
be minimised as far as possible and dealt with professionally. A small, organic henna stain 
will be applied to the area where the intervention will take place. The intervention process 
will involve placing a reasonable amount of pressure over the infraspinatus muscle for a 
short period of time i.e. up to 90 seconds. 
 
WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you decide to 
participate, you are free to withdraw your consent at any time without giving a reason and 
without any consequences. If you wish to withdraw your consent, you must inform me as 
soon as possible. 
 
IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME, OR 
PAYMENT DUE TO ME: You will not be paid to participate in this study and you will not bear 
any expenses. 
 
Participant Initials:__________ 
 
RISKS INVOLVED IN PARTICIPATION: The risk anticipated for this study is mild stiffness 
or pain following intervention which should last no more than 24 hours.  
 
BENEFITS INVOLVED IN PARTICIPATION: Ischaemic compression is a technique that 
has been shown to treat myofascial trigger points successfully with minimal to no risk 
involved. You may benefit from a reduction of pain, increased pain threshold and tolerance, 
increased range of motion of the shoulder and a decrease in muscle spasticity.  
 
WILL MY PARTICIPATION IN THIS STUDY BE KEPT CONFIDENTIAL? Yes. Names on 
the data sheet will be removed once analysis starts. All data and back-ups thereof will be 
kept in password protected folders and/or locked away as applicable. Only I or my research 
supervisor will be authorised to use and/or disclose your anonymised information in 
connection with this research study. Any other person wishing to work with you anonymised 
information as part of the research process (e.g. an independent data coder) will be required 
to sign a confidentiality agreement before being allowed to do so. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results will 
be written into a research report that will be  assessed. In some cases, results may also be 
published in a scientific journal. In either case, you will not be identifiable in any documents, 
reports or publications. You will be given access to the study results if you would like to see 
them, by contacting me.  
  
WHO IS ORGANISING AND FUNDING THE STUDY?  The study is being organised by me, 
under the guidance of my research supervisor at the Department of Chiropractic in the 
University of Johannesburg. The University of Johannesburg has afforded me a Supervisor 
Linked Bursary in order to cover the expenses associated with this study. 
 
WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed to 
start, it was reviewed in order to protect your interests. This review was done first by the 
Department of Chiropractic, and then secondly by the Faculty of Health Sciences Research 
Ethics Committee at the University of Johannesburg. In both cases, the study was approved. 
 
WHAT IF THERE IS A PROBLEM? If you have any concerns or complaints about this 
research study, its procedures or risks and benefits, you should ask me. You should contact 
me at any time if you feel you have any concerns about being a part of this study. My contact 
details are:  
 
Anisha Magoo 
072 869 2241 
anisha.magoo@gmail.com 
 
You may also contact my research supervisor: 
Dr Caroline Hay 
carolineh@uj.ac.za 
 
If you feel that any questions or complaints regarding your participation in this study have 
not been dealt with adequately, you may contact the Chairperson of the Faculty of Health 
Sciences Research Ethics Committee at the University of Johannesburg: 
 
Prof. Christopher Stein 
Tel: 011 559-6564 
Email: cstein@uj.ac.za  
 
FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more 
specific information about this research project information, have any questions, concerns 
or complaints about this research study, its procedures, risks and benefits, you should 
communicate with me using any of the contact details given above. 
 
 
Researcher: 
 
Anisha Magoo 
<Signature> 
  
Participant Initials: _________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix C - Consent Form 
 
 
            
DEPARTMENT OF CHIROPRACTIC 
RESEARCH CONSENT FORM 
 
THE EFFECT OF DURATION OF ISCHAEMIC COMPRESSION ON ACTIVE TRIGGER 
POINTS IN THE INFRAPSINATUS MUSCLE 
 
Please initial each box below: 
 
 
       I confirm that I have read and understand the information letter dated Click 
here to enter the date, as is appears on the information sheet. for the above study. I have 
had the opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
 
                    I understand that my participation is voluntary and that I am free to withdraw 
from this study at any time without giving any reason and without any consequences to me. 
 
 
      I agree to take part in the above study. 
 
 
 
_______________________       ________________                      ________________ 
     Name of Participant     Signature of Participant                     Date 
 
 
_______________________       _________________              _______________ 
      Name of Researcher    Signature of Researcher         Date 
 
 Appendix D - Numerical pain rating scale 
 
NUMERICAL PAIN RATING SCALE (Bijur et al., 2003) 
 
Patient: _____________________________                            
Date: _______________________________ 
 
 
This is a scale used to express the extent of pain in the shoulder at this point in time. It 
ranges from 0 – 10.  
0 = No pain at all 
10 = Worst pain imaginable 
 
 
 
Please place an X in the block that correlates with a number that represents the pain that 
you are experiencing: 
 
0 1 2 3 4 5 6 7 8 9 10 
           
 
No Pain                                                                                                           
Worst Pain 
 
 
 
 
 
 
 
 
 
 
 Appendix E: Case history 
 
UNIVERSITY OF JOHANNESBURG 
CHIROPRACTIC DAY CLINIC 
 
CASE HISTORY 
 
 
Date:  ________________________________ 
 
Patient:  ________________________________  File No: ___________________________ 
 
Occupation: ________________________________  Age: __________          Sex: ________ 
 
Student:  ________________________________  Signature: _________________________ 
 
 
FOR CLINICIAN USE ONLY: 
 
Initial visit clinician: ________________________________  Signature:       ______________________ 
 
Case History:
 _______________________________________________________________________________________ 
 
 
 _______________________________________________________________________________________ 
 
 
 _______________________________________________________________________________________ 
 
 
 _______________________________________________________________________________________ 
 
 
 _______________________________________________________________________________________ 
 
 
 _______________________________________________________________________________________ 
  
 
Examination: 
Previous:   UJ     Current:  UJ 
Other       Other 
 
X-ray Studies: 
Previous:  UJ     Current:   UJ 
Other       Other 
 
Clinical Path. Lab: 
Previous:   UJ     Current:   UJ 
Other       Other 
 
Case status: 
PTT:   Conditional:   Signed off:   Final sign 
out: 
 
Recommendations: 
RESEARCH 
  
Students case history: 
 
1. Source of History: _________________________________________ 
 
2. Chief Complaint in patients own words: 
 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. ANY OTHER COMPLAINTS 
 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
 
 
 
 
 
 
3. PRESENT ILLNESS/PRIMARY COMPLAINT 
 
Location 
 
 
Onset 
 
 
Duration 
 
 
Frequency 
 
 
Pain Character 
 
 
Progression 
 
 
Aggravating Factors 
 
 
Relieving Factors 
 
 
Ass Signs & Symptoms 
 
 
Previous Occurrence 
 
 
Past Tx and Outcomes 
 
 
 
4. PAST HISTORY 
 
General Health Status 
 
 
Childhood Illnesses 
 
 
Adult Illnesses 
 
 
Psychiatric Illnesses 
 
 
Accidents 
 
 
 
 
Traumatic Injuries 
 
 
 
 
Surgeries 
 
 
 
Hospitalizations 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. CURRENT HEALTH STATUS & LIFESTYLE 
Allergies 
 
 
Immunizations 
 
 
Screening Tests 
 
 
Environmental Hazards 
 
 
Safety Measures 
 
 
Progression 
 
 
Exercise and Leisure 
 
 
Sleep Patterns 
 
 
Diet 
 
 
Current Mediation 
 
 
Tobacco 
 
 
Alcohol 
 
 
Social Drugs 
 
 
Other
 
 
 
 
 
7. FAMILY HISTORY 
Diabetes Mellitus 
 
 
Heart Disease 
 
 
TB 
 
 
HBP 
 
 
Stroke 
 
 
Kidney Disease 
 
 
Cancer 
 
 
Arthritis 
 
 
Anaemia 
 
 
Headaches 
 
 
Thyroid Diseases 
 
 
Epilepsy 
 
 
Mental Illness 
 
 
Alcoholism 
 
 
Drug Addiction 
 
 
Other 
 
 
 
 
 
8.  PSYCHOSOCIAL HISTORY 
 
Home Situation 
 
 
Daily Life 
 
 
Important Experiences 
 
 
Religious Beliefs 
 
 
Other 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9. REVIEW OF SYSTEMS 
 
General 
 
 
Skin 
 
 
Head 
 
 
Eyes 
 
 
Ears 
 
 
Noses / Sinuses 
 
 
Mouth / Throat 
 
 
Neck 
 
 
Breasts 
 
 
Respiratory 
 
 
Cardiac 
 
 
Gastrointestinal 
 
 
Urinary 
 
 
Genital/Sexual 
Function 
 
 
Vascular 
 
 
Musculoskeletal 
 
 
Neurological 
 
 
Haematological 
 
 
Endocrine 
 
 
Psychiatric 
 
 
Other 
 
 
 
 
 
 Appendix F – Physical examination 
 
 
UNIVERSITY OF JOHANNESBURG 
CHIROPRACTIC DAY CLINIC 
 
PHYSICAL EXAMINATION 
 
Underline abnormal findings in RED    Date: ________________________ 
 
Patient:  ________________________________  File No:  ________________________ 
 
Clinician:  ________________________________  Signature: _______________________ 
 
Student:  ________________________________  Signature: _______________________ 
________________________________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VITAL SIGNS 
 
Height 
 
 
Weight 
 
 
Temperature 
 
 
Heart Rate 
 
 
Pulse 
 
 
Respiratory Rate 
 
 
 
BLOOD PRESSURE 
 
 Left 
 
Right 
 
Arms 
 
  
Legs 
 
  
 
General Appearance 
__________________________________________ 
 
__________________________________________ 
 
__________________________________________ 
STANDING EXAMINATION 
 
Minor’s Sign  
Skin Changes  
Posture 
• Erect 
• Adams 
 
Romberg’s Sign  
Pronator Drift  
Trendelenburg Sign  
Gait 
• Rhythm 
• Balance 
• Pendulousness 
• On toes 
• On heels 
• Tandem 
 
 
Half Squat  
Scapular Winging  
Muscle Tone  
Spasticity / Rigidity  
Chest measurement 
• Inspiration 
• Expiration 
 
_________________ cm 
_________________ cm 
Visual Acuity  
Lumbar Spine ROM 
• Flexion (90º) 
• Extension (50º) 
• Lat. Flexion (30º) 
• Rotation (35º) 
           
 
 
  
RESEARCH 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEATED EXAMINATION 
 
Spinal Posture  
Head 
• Hair & Skin 
• Scalp 
• Skull 
• Face 
 
Eyes 
• Observation 
- Conjunctiva 
- Sclera 
- Eyebrows & Lids 
- Lacrimal Glands 
- Nasolacrimal 
Duct 
- Position 
- Alignment 
- Cornea / Lens 
• Corneal Reflex 
• Ocular Movements 
• Visual Fields 
• Accommodation 
• Opthalmoscopy 
- Iris 
- Pupils 
- Red Reflex 
- Optic Disc 
- Macula 
- Vitreous 
- Lens 
 
Ears 
• Inspection 
- Auricle 
- Ear Canal 
- Drum 
• Auditory Acuity 
• Weber Test 
• Rinne Test 
 
Nose 
• External Inspection 
• Internal Inspection 
- Septum 
- Turbinate’s 
- Olfaction 
 
Sinuses 
• Tenderness 
• Transillumination 
 
 
SEATED EXAMINATION Cont. 
 
Mouth & Pharynx 
• Lips 
• Buccal Mucosa 
• Gums & Teeth 
• Roof 
• Tongue 
- Inspection 
- Movements 
- Taste 
- Palpation 
• Pharynx – CN X 
 
TMJ 
• Inspection 
- ROM 
- Deviation 
• Palpation 
- Crepitus 
- Tenderness 
 
Neck 
• Posture 
• Size / Swellings 
• Scars 
• Discolorations 
• Hairline 
• Lymph Nodes 
• Tracheal 
Alignment 
• Thyroid & Carotids  
 
Cervical Spine ROM 
• Flexion (45º) 
• Extension (55º) 
• Lat. Flexion (40º) 
• Rotation (70º) 
     
Peripheral Vascular 
• Inspection 
- Pigmentation, 
Skin, Nailbeds, 
Hair loss 
• Palpation 
- Pulses, Lymph 
nodes, Skin 
Temp 
• Manual Compression 
• Retrograde Filling 
• Arterial Insufficiency 
• Allan’s Test 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
BREAST 
 
Inspection 
• Skin 
• Size 
• Contour 
• Nipples 
• Arms Overhead 
• Hands Against Hips 
• Leaning Forward 
 
Palpation 
• Axillary Lymph Nodes 
• Breast 
• Breast tail 
 
 
THORAX – HEART AND LUNGS 
 
Inspection 
• Skin 
• Shape 
• Respiratory Distress 
• Rhythm 
• Depth 
• Effort 
• Intercostal Retraction 
 
Palpation 
• Tenderness 
• Masses 
• Respiratory 
Expansion 
• Tactile Fremitus 
• JVP 
• PMI 
 
Percussion 
• Lungs (posterior) 
• Diaphragmatic 
excursion 
• Kidney Punch 
 
Auscultation 
• Breath Sounds 
• Adventitious Sounds 
• Voice Sounds 
• Heart Auscultation 
• Heart Murmurs 
 
 
ABDOMINAL 
 
Inspection 
• Skin 
• Umbilicus 
• Contour 
• Peristalsis 
• Pulsations 
• Hernias 
 
Auscultation 
• Bowel Sounds 
• Bruits 
 
Percussion 
• General 
• Liver 
• Spleen 
 
Palpation 
• Superficial Reflex 
• Cough 
• Light 
• Rebound Tenderness 
• Deep 
• Liver 
• Spleen 
• Kidneys 
• Aorta 
• Abdominal Masses 
• Shifting Dullness 
• Fluid Wave 
 
Acute Abdomen 
• Where pain began? 
• Moved to where? 
• Cough 
• Tenderness 
• Guarding / Rigidity 
• Rebound Tenderness 
 
Special Tests 
• Rovsing’s Sign 
• Psoas Sign 
• Obturator Sign 
• Cutaneous 
Hyperaesthesia 
• Murphy’s Sign 
• Rectal Examination 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MUSCULOSKELETAL 
 
Shoulder 
• Observation 
- Skin 
- Symmetry 
• ROM 
- Glenohumeral 
- Scapulo-thoracic 
- Acromioclavicular 
- Elbow 
- Wrist 
 
Hip 
• Flexion (90° / 120°) 
• Extension (15°) 
• Abduction (45°) 
• Adduction (30°) 
• Internal Rotation (40°) 
• External Rotation (45°) 
Left Right 
  
  
  
  
  
  
Knee 
• Flexion (30°) 
• Extension (0° / 15°) 
Left Right 
  
  
Ankle 
• Plantar Flexion (45°) 
• Dorsi Flexion (20°) 
• Inversion (30°) 
• Eversion (20°) 
Left Right 
  
  
  
  
Leg Length 
• Apparent 
• Actual 
Left Right 
  
  
 
 
 
 
CO-ORDINATION AND CEREBELLAR TESTING 
 
Vertigo  
Ataxic Gait  
Nystagmus  
Intention Tremor  
Slurring/ Staccato Speech  
Hypotension  
Dysmetria (Point to point)  
Dysdiachokinesia  
Titubation  
 
 
NEUROLOGICAL ASSESSMENT 
 
DERMATOMES 
 Left Right 
Cervical   
C2   
C3   
C4   
C5   
C6   
C7   
C8   
T1   
T2   
   
Lumbar   
T12   
L1   
L2   
L3   
L4   
L5   
S1   
S2   
S3   
 
REFLEXES 
 Level Left Right 
Cervical    
Biceps C5   
Brachioradialis C6   
Triceps C7   
    
Lumbar    
Patella L3 / L4   
Medial Hamstring L5   
Lateral Hamstring S1   
Tibialis Posterior  L4 / L5   
Achilles  S1 / S2   
Plantar Reflex    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MENTAL STATUS 
 
Appearance & Behaviour 
• LOC 
• Posture 
• Motor Behaviour 
• Dress, Grooming 
• Facial Expression 
• Affect 
 
Speed & Language 
• Quantity 
• Rate 
• Volume 
• Fluency 
• Aphasia (pm) 
 
Mood  
Memory 
• Orientation 
• Remote Memory 
• Recent Memory 
• New Learning Ability 
 
Higher Cognitive Function 
• Information 
• Vocabulary 
• Abstract Thinking 
 
 
 
NEUROLOGICAL ASSESSMENT 
MYOTOMES 
 Level Left Right 
Cervical    
Neck Forward 
Flexion 
C1 / C2   
Neck Lateral 
Flexion 
C3   
Shoulder 
Elevation 
C4   
Shoulder 
Abduction 
C5   
Elbow Flexion 
 
C5   
Elbow Extension 
 
C7   
Elbow Flexion 
 
C6   
Forearm 
Pronation 
C6   
Forearm 
Supination 
C6   
Wrist Extension 
 
C6   
Wrist Flexion 
 
C7   
Finger Flexion 
 
C8   
Finger 
Abduction 
 
T1   
Finger 
Adduction 
 
T1   
 
 
   
Lumbar    
Hip Flexion 
 
L1 / L2   
Knee Extension 
 
L2 / L3 
/ L4 
  
Knee Flexion 
 
L5 / S1   
Hip Internal 
Rotation 
L4 / L5   
Hip External 
Rotation 
L5 / S1   
Hip Adduction 
 
L2 / L3 
/ L4 
  
Hip Abduction 
 
L4 / L5   
Ankle 
Dorsiflexion 
L4 / L5   
Ankle Plantar 
Flexion 
S1 / S2   
Hallux Extension 
 
L5   
Eversion 
 
S1   
Inversion 
 
L4   
Hip Extension 
 
L5 / S1   
 
 
CRANIAL NERVES 
   Left        Right 
CN I – Olfactory   
CN II – Optic   
CN III – Oculomotor   
CN IV - Trochlear   
CN V – Trigeminal 
• Motor 
• Sensory 
  
CN VI – Abducents   
CN VII – Facial 
• Motor 
• Sensory 
  
CN VIII - Vestibulocochlear   
CN IX – Glossopharyngeal   
CN X – Vagus   
CN XI – Spinal Accessory   
CN XII - Hypoglossal   
 
 
 Appendix G- Cervical spine regional examination 
 
 
UNIVERSITY OF JOHANNESBURG 
CHIROPRACTIC DAY CLINIC 
 
REGIONAL EXAMINATION 
CERVICAL SPINE 
 
Date:  ___________________________ 
 
Patient:  ___________________________  File No: ___________________________ 
 
Clinician:  ___________________________  Signature: _________________________ 
 
Student:  ___________________________  Signature: _________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION 
 
Posture  
Size  
Swellings  
Scars  
Discolouration’s  
Hairline  
Bony Contours  
Soft Tissue Contours  
Shoulder Level  
Muscle Spasm  
Facial Expression  
Antalgic List  
Torticollis  
Plumb lines 
• Frontal plane 
• Sagittal Plane 
 
 
PALPATION 
 
Lymph Nodes  
Trachea  
Thyroid Gland  
Pulses 
• Carotid 
• Subclavian 
• Brachial  
• Radial 
 
Tenderness  
Muscle Tone  
 
MYOFACIAL – ACTIVE TRIGGER POINTS 
 
 Left Right 
SCM   
Trapezius   
Scalene Anterior   
Scalene Posterior   
Scalene Medius   
Levator Scapula   
Posterior Cervicals   
Rhomboids   
Sub Occipitals   
Masseter   
Temporalis   
 
RANGE OF MOTION 
 
 
  
RESEARCH 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RANGE OF MOTION 
 Active ROM Passive ROM Resisted Isometric 
 Left Right Left Right Left Right 
Flexion (45º - 90º)       
Extension (55 º - 70 º)       
Lateral Flexion (20 º - 45 º)       
Rotation (70 º - 90 º)       
 
NEUROLOGICAL ASSESSMENT 
DERMATOMES 
 Left Right 
Cervical   
C2   
C3   
C4   
C5   
C6   
C7   
C8   
T1   
T2   
 
DISCRIMATIVE SENSATIONS 
 Left Right 
Stereognosis   
Graphesthesia   
Two Point 
Discrimination 
  
Point Localisation   
Extinction   
 
 
 
 
 
 
 
 
 
 
 
 
 
NEUROLOGICAL ASSESSMENT 
MYOTOMES 
 Level Left Right 
Neck 
Forward 
Flexion 
C1 / 
C2 
  
Neck Lateral 
Flexion 
C3   
Shoulder 
Elevation 
C4   
Shoulder 
Abduction 
C5   
Elbow 
Flexion 
 
C5   
Elbow 
Extension 
C7   
Elbow 
Flexion 
 
C6   
Forearm 
Pronation 
C6   
Forearm 
Supination 
C6   
Wrist 
Extension 
C6   
Wrist Flexion 
 
C7   
Finger 
Flexion 
 
C8   
Finger 
Abduction 
T1   
Finger 
Adduction 
T1   
 
MUSCLE GRADING 
• 0 - No contraction detected 
• 1 - Barely detectable flicker or trace of 
contraction 
• 2 - Active movement with gravity 
eliminated 
• 3 - Active movement against gravity 
• 4 - Active movement against gravity and 
some resistance. 
NEUROLOGICAL ASSESSMENT 
REFLEXES 
 Level Left Right 
Biceps C5   
Brachioradialis C6   
Triceps C7   
 
REFLEX GRADING 
• 4+ Very brisk, hyperactive. Perform 
ankle clonus.   
• 2+ Average; normal  
• 1+ Somewhat diminished; low normal. 
• 0 No response 
 
 
 
 
 
 
 
 
NEUROLOGICAL ASSESSMENT 
CO_ORDINATION 
 Left Right 
Rapid Alternating 
Movements 
  
Point to Point 
Movements 
  
 
 
NEUROLOGICAL ASSESSMENT 
STANCE 
 Left Right 
Romberg’s    
Pronator Drift   
Arm Tapping   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORTHOPAEDIC TESTS 
 Left Right 
Doorbell Sign   
Max Cervical Compression   
Spurling’s Manoeuvre   
Lateral Compression   
Kemp’s Test   
Cervical Distraction   
Shoulder Abduction Test   
Shoulder Depression Test   
Dizziness Rotation Test   
Lhermitte’s Sign   
Brachial Plexus Tension 
• Median 
• Radial 
• Ulna 
  
Carpal Tunnel Tests 
• Tinel’s at the Wrist 
• Phalen’s 
• Reverse Phalen’s 
  
TOS Testing 
• Halstead’s Test 
• Adson’s Test 
• Eden’s Traction Test 
• Wright’s Test (Pec 
Minor) 
• Costoclavicular Test 
  
 
 
VASCULAR TESTING 
 Left Right 
Blood Pressure   
Carotids Pulse   
Subclavian Pulse   
Brachial Pulse   
Radial Pulse   
JVP   
Auscultation of Carotid   
Auscultation of Subclavian   
Allen’s Test   
Capillary Refill   
Examination of the Eye   
   
VBAI Testing 
Wallenberg’s Test   
Maigne’s Test   
Hautant’s Test   
Underberger’s Test   
 
CRANIAL NERVES 
 Left Right 
CN I    
Smell   
CN II   
Visual acuity   
Optic fundi   
Visual fields by 
confrontation 
  
CN II and III    
Pupils   
Reactions to light   
Near response   
CN III, IV and IV   
Extraocular movements   
Ptosis   
CN V   
Sensory   
Motor   
Corneal reflex   
CN VII   
Muscles of face   
CN VIII   
Auditory acuity   
Weber   
Rinne   
CN IX and X   
Voice   
Movements of soft 
palate and pharynx 
  
Gag reflex   
CN XI   
Shoulder elevation   
Neck rotation   
CN XII   
Asymmetry/deviation of 
tongue 
  
Fasciculation’s   
MOTION PALPATION 
 
 Left Right 
C0   
C0 / C1   
C1 / C2   
C2 / C3   
C3 / C4   
C4 / C5   
C5 / C6   
C6 / C7   
C7 / T1   
T1 / T2   
T2 / T3   
T3 / T4   
T4 / T5   
T5 / T6   
T6 / T7   
 
GENERAL COMMENTS: 
 
 
_____________________________________ 
 
_____________________________________ 
 
_____________________________________ 
 Appendix H- Shoulder regional examination 
 
 
UNIVERSITY OF JOHANNESBURG 
CHIROPRACTIC DAY CLINIC 
 
REGIONAL EXAMINATION 
THE SHOULDER 
 
Date:  ___________________________ 
 
Patient:  ___________________________  File No: ___________________________ 
 
Clinician:  ___________________________  Signature: _________________________ 
 
Student:  ___________________________  Signature: _________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION (Standing and seated) 
Posture  
Skin (Bruises / Scars)  
Congenital deformities  
Developmental deformities  
Traumatic deformities  
Asymmetry  
Muscle bulk/atrophy  
Swellings  
Resting position  
Winging of scapula  
  
General Notes 
 
 
 
 
 
PALPATION 
 Left Right 
Anterior 
Clavicle   
Coracoid   
Sternum   
Humerus   
Biceps tendon   
Sternoclavicular joint   
Acromioclavicular joint   
Ribs and coastal cartilage   
Rotator cuff muscles   
Axilla   
   
Posterior 
Scapula   
Spine of scapula   
Triceps tendon   
Spinous process of C 
Spine 
  
Spinous process of T 
Spine 
  
 MYOFASCIAL 
 Left Right 
Supraspinatus   
Infraspinatus   
Teres Minor   
Subscapularis   
Biceps   
Triceps   
Trapezius   
Levator Scapula   
Rhomboid Major   
Rhomboid Minor   
Scalene Muscles   
 
MYOFASCIAL cont. 
 Left Right 
Latissimus Dorsi   
Deltoid   
Biceps Brachii   
Coracobrachialis   
Triceps Brachii   
Pectoralis Major   
Pectoralis Minor   
Serratus Anterior   
 
RESEARCH 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RANGE OF MOTION 
 Active ROM Passive ROM Resisted Isometric 
 Left Right Left Right Left Right 
Elevation through abduction (170º - 180º)       
Painful Arc with Abduction       
Elevation through forward flexion (160 º - 180 
º) 
      
Elevation in the scapular plane (170 º - 180 º)       
Lateral Rotation / External (80º - 90º)       
Medial Rotation / Internal (60º - 100º)       
Extension (50º - 60º)       
Adduction (50º - 75º)       
Apley Scratch       
Horizontal Abduction (130º)       
Circumduction (200º)       
Elbow Flexion       
Elbow Extension       
Scapulohumeral Rhythm       
 
INSTABILITY TESTS 
 Left Right 
Anterior Instability 
Rockwood’s Test   
Crank’s Test   
Fowler’s / Jobe’s Tests   
Rowe’s Test   
Fulcrum Test   
   
Posterior Instability 
Posterior Apprehension   
Push-Pull Test   
   
Multidirectional Instability 
Sulcus Sign / Test   
Feagin’s Test   
 
 
TESTS FOR IMPINGEMENTS 
 
 Left Right 
Neer’s Impingement   
Hawkins’s Test   
 
 
TESTS FOR LABRAL TEARS 
 
 Left Right 
Anterior Slide Test   
O’Brien’s Test   
Crank’s Test   
 
 
TESTS FOR ACROMIOCLAVICULAR JOINT 
PATHOLOGY 
 
 Left Right 
Cross Arm Test   
Scarf Wrap Around   
Resisted Extension   
AC Joint Shear Test   
 
 
TESTS FOR MUSCLE / TENDON PATHOLOGY 
 
 Left Right 
Supraspinatus Test   
Drop Arm Test   
Lift Off Test   
Pec. Major Contracture   
Speed’s Test   
Heuter’s Test   
Yergason’s Test   
Luddington’s Test   
 
 
TESTS FOR NEURLOGICAL FUNCTION 
 
 Left Right 
Brachial Plexus Tension   
Tinel’s at the Elbow    
Tinel’s at the Wrist   
Phalen’s   
Reverse Phalen’s   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEUROLOGICAL ASSESSMENT 
Dermatomes 
 Left Right 
C4   
C5   
C6   
C7   
C8   
T1   
T2   
T3   
T4   
T5   
T6   
 
Reflexes and Cutaneous Distribution 
 Left Right 
Biceps (C5-C6)   
Triceps (C7-C8)   
Pectoralis Major – 
Clavicular Portion  
(C5-C6) 
  
Pectoralis Major – 
Sternocostal Portion 
(C7-T1) 
  
 
JOINT PLAY 
 Left Right 
Glenohumeral Joint 
Backward Glide of 
Humerus 
  
Forward Glide of 
Humerus 
  
Lateral Distraction of 
Humerus 
  
Caudal Glide of 
Humerus 
  
Backward Glide of 
Humerus (Abduction) 
  
Lateral Glide of 
Humerus (Abduction) 
  
   
Acromioclavicular Joint 
A-P glide   
P-A Glide   
Superior – Inferior   
Inferior - Superior   
   
Sternoclavicular Joint 
A-P glide   
P-A Glide   
Superior – Inferior   
Inferior - Superior   
   
Scapula 
Elevation   
Depression   
Protraction   
Retraction   
Medial Rotation   
Lateral Rotation   
Scapulohumeral rhythm   
 
 
GENERAL COMMENTS: 
 
 
_____________________________________ 
 
_____________________________________ 
 
_____________________________________ 
 
_____________________________________ 
 
_____________________________________ 
 
_____________________________________ 
 
_____________________________________ 
 
 Appendix I- SOAP note 
 
 
 
UNIVERSITY OF JOHANNESBURG 
CHIROPRACTIC DAY CLINIC 
SOAP NOTE 
 
Patient: Visit Number:  
File Number: Student: 
Date: Clinician: 
S: 
 
 
 
 
O:  
A: ICD-10 Code 
 
 
 
 
P: Procedure Codes 
Home Advice: 
 
 
 
 
Comments: 
 
Patient: Visit Number:  
File Number: Student: 
Date: Clinician: 
S: 
 
 
 
 
O:  
A: ICD-10 Code 
 
 
 
 
P: Procedure Codes 
Home Advice: 
 
 
 
 
Comments: 
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